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     Summary 
 Transport of proteins across the bacterial cell envelope is a basic function 
performed by bacteria. The secretion pathways used for the transport of proteins are 
known as secretion systems. Secreted proteins are involved in various functions such as 
biogenesis of the cell envelope, motility and intercellular communication. To date, six 
types of secretion systems have been identified in gram-negative pathogenic bacteria. A 
detailed introduction to bacterial secretion systems in gram-negative bacteria is given in 
chapter1. 
 
 Enterohemorrhagic Escherichia coli (EHEC) is a common cause of severe 
hemorrhagic colitis. EHEC’s virulence is dependent upon a type III secretion system 
(T3SS) encoded by 41 genes. These genes are organized in several operons that are 
clustered in the locus of enterocyte effacement (LEE). Most of the LEE genes, including 
grlA and grlR, are positively regulated by Ler, and Ler expression is in turn positively and 
negatively modulated by the proteins GrlA and GrlR, respectively. However, the 
molecular basis for the GrlA and GrlR activity is still elusive. In chapter 2 of this thesis, 
we report the crystal structure of GrlR at 1.9 Å resolution. It consists of a typical β-barrel 
fold with eight β-strands containing an internal hydrophobic cavity and a plug-like loop 
on one side of the barrel. Furthermore, a unique surface-exposed EDED (Glu-Asp-Glu-
Asp) motif is identified to be critical for GrlA–GrlR interaction and for the repressive 




 GrlR adopts the typical lipocalin fold, which comprises an eight stranded β-barrel 
followed by an α-helix at the C-terminus. Lipocalins are a broad family of proteins with 
diverse functions. They are present in eukaryotes as well as gram-negative bacteria. In 
chapter 3 of this thesis we report the structure of lipid-GrlR complex and the details of the 
binding of a lipid to recombinant GrlR as verified by isothermal titration calorimetry. 
Based on these results we identified glycerophosphatidyl phosphatidic acids and 
glycerophosphatidylethanolamines as potential lipid ligands of GrlR. In addition, we 
identified an endogenously bound lipid species to GrlR by electrospray ionization mass 
spectrometry. Our studies demonstrate the hitherto unknown lipid binding property of 
GrlR. We speculate that this property of GrlR may help to anchor and orient GrlR on 
membrane to facilitate its interaction with the positive regulator GrlA. 
 
 The type VI secretion system (T6SS) is a recently identified secretion system used 
by gram-negative bacteria to inject virulence proteins into host cells. The T6SS cluster in 
Edwardsiella tarda is named as Evp (Edwardsiella virulence protein) and it contains 16 
different genes that are classified into intracellular apparatus proteins, secreted proteins 
and a group of proteins non-essential for T6SS. It has been shown that the secretion of the 
apparatus protein Hcp1 from Pseudomonas aeruginosa, a close homolog of EvpC, is an 
essential characteristic of a functional T6SS. Here we report the crystal structure of EvpC 
from E. tarda refined at 2.8 Å resolution. EvpC is comprised of a loose β-barrel domain 
with extended loops. We speculate that similar to its homolog Hcp1, EvpC can form a 
hexameric ring with a diameter of 40Ǻ that is capable of transporting small proteins and 
ligands. Analytical ultra centrifugation studies on the oligomerization state of EvpC 
showed that depending on concentration, EvpC can exist as both dimer and hexamer in 
xi 
 
solution. Structure based mutational studies on EvpC have identified the critical residues 
at the N-terminal region that are essential for the function of this protein. 
 
 Secretion systems in pathogenic bacteria play a major role in delivering virulence 
proteins into host cells. Proteins associated with a secretion system are new targets for 
potential drugs and vaccines, which can prevent diseases by impairing essential virulence 
properties. Our studies broaden the understanding of the structure, function and assembly 
of protein secretion system, particularly the type III and VI secretion systems in gram-
negative bacteria which will ultimately aid in drug development.  
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1.1. Host-Pathogen Interaction 
 The interaction between bacterial pathogens and their host such as humans, 
animals and plants is an important area of study in microbiological research.  The findings 
that emerge from these studies will aid drug development, as well as early diagnosis and 
identification of pathogenic diseases. Host-pathogen interactions may be symbiotic or 
pathogenic. These interactions can cause a wide variety of responses in the host cell. The 
same pathogens can cause mild, sub-lethal or lethal infections, depending on the host. The 
host immune response is the primary response against any pathogenic infection and it uses 
a wide variety of mechanisms to neutralize and remove the pathogenic bacteria. The 
pathogens also employ a wide variety of techniques to evade the host response. One of the 
major weapons used by pathogens against the host is their virulence proteins, which are 
capable of subverting the host immune response. 
 The genes that are responsible for producing virulence proteins are generally 
clustered together in the genome and these gene clusters are known as pathogenicity 
islands. The protein secretion system in bacteria plays a major role in delivering these 
proteins into the host cell. Due to the presence of two membranes (outer membrane and 
inner membrane), protein transport in gram-negative bacteria needs a complex secretion 
system.  Protein secretion systems in gram-negative bacteria have received special 
attention due to this complexity. An overview of the pathogenicity islands (PAIs) and 







1.2. Pathogenicity Islands (PAIs) 
 PAIs are groups of genetic elements present in the genome of a pathogenic 
organism and play a major role in the development of disease and virulence. PAIs were 
discovered by Jorg Hacker (Knapp et al., 1986; Hacker et al., 1990). DNA fragments 
consisting of more than one virulence gene were reported earlier and they were known as 
virulence blocks (High et al., 1988; Hacker, 1990). The first report of pathogenicity DNA 
islands came after the loss of two linked virulence gene clusters by a single deletion event 
in Escherichia coli strain 536 (Hacker et al., 1990; Blum et al., 1994). Hacker and co-
workers generated a nonpathogenic strain of E. coli by deleting the PAI (Hacker et al., 
1990). The size and genetic structure of these E. coli PAIs were studied in detail (Hacker 
et al., 1983; Knapp et al., 1985; Hacker et al., 1990).  
Schmidt and Hensel (2004) have described some of the genetic features of PAIs which are 
as follows.  
(i) One or more virulence genes are present in a PAI.  
(ii) PAIs are present mainly in pathogenic strains of bacteria. 
(iii) The nucleotide composition of the core genome is different from that of PAI. 
(iv) Large genomic regions are covered by PAI. 
(v) Generally, PAIs are located close to tRNA genes. 
(vi) PAIs are often flanked by direct repeats (DR) and they are associated with mobile 
genetic elements. Direct repeats are small DNA sequences (16 to 20 bp) with a perfect or 
nearly perfect sequence repetition. 
(vii) When compared with normal mutations, those in PAIs are unstable and may get 
deleted more frequently. 
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(viii) PAIs are sometimes heterogeneous due to the accumulation of different genetic 
elements into the same chromosomal site. But in some cases, only one insertion is present 
which may be more homogeneous.  
In a single organism, PAIs can perform different functions according to the environmental 
conditions. In E. coli, these pathogenicity islands help the bacterium to produce virulence 
proteins as well as in adapting to various environmental conditions (Knapp et al., 1986; 
Tauschek et al., 2002). For e.g; E. coli is involved in the development of diseases such as 
diarrhea and hemolytic-uremic syndrome after colonizing in the large intestine, watery 
diarrhea after colonizing in the small intestine and urinary tract infection after survival and 
colonizing in the bladder. 
 Most of the PAIs are acquired by bacteria during evolution and in some species, 
addition of this new gene cluster has resulted in the transformation of an avirulent species 
to virulent species. These types of evolutionary changes usually take place at a slow pace 
(normally a few million years), but in some bacteria e.g.  Vibrio cholerae, a virulent strain 
developed in less than 100 years from its avirulent form (Waldor and Mekalanos, 1996). 
Another important character associated with PAI is that they provide resistance to 
antibiotics as well as environmental changes. These PAIs also serve as markers to identify 
new strains and species of pathogens. A schematic representation of a PAI is given in 
Fig.1.1. The genes encoding the bacterial secretion system proteins are clustered in the 
PAI. A detailed description of the major protein secretion systems present in gram-




Figure 1.1. General structure of a Pathogenicity Island. (A) Typical PAIs are distinct 
regions of DNA that are present in the genome of pathogenic bacteria but absent in 
nonpathogenic strains of the same or related species. PAIs are mostly inserted in the 
backbone genome of the host strain (dark grey bars) in specific sites that are frequently 
tRNA or tRNA-like genes (hached grey bar). Mobility genes, such as integrases (int), are 
frequently located at the beginning of the island, close to the tRNA locus or the respective 
attachment site. PAI harbor one or more genes that are linked to virulence (V1 to V4) and 
are frequently interspersed with other mobility elements, such as IS elements (Isc, 
complete insertion element) or remnants of IS elements (ISd, defective insertion element). 
The PAI boundaries are frequently determined by direct repeats (DR, triangle), which are 
used for insertion and deletion processes. (B) A characteristic feature of PAI is the G-C 
content that is different from that of the core genome. This feature is often used to identify 
new PAI. (This figure is adapted from Schmidt and Hensel, 2004) 
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1.3. Protein Secretion Systems 
 Transport of proteins across the bacterial cell envelope is a basic function 
performed by bacteria. The secretion pathways used for the transport of proteins are 
known as secretion systems and they vary from simple to complex systems. Recently, 
several three-dimensional structures of proteins associated with these secretion systems 
have been published which enhanced our understanding about them. These protein 
secretion systems are getting identified in new pathogens as well. In addition, recent 
studies reveal the presence of more than one secretion system in the same pathogen.  
Secreted proteins have various functions in processes such as biogenesis of the cell 
envelope, motility and intercellular communication.  Bacterial virulence factors that 
enable a progressive colonization of host organisms are commonly secreted proteins 
(Gerlach and Hensel, 2007). To date six secretion systems have been identified in gram-
negative pathogenic bacteria (Fig. 1.2). They vary from simple systems that involve a few 
proteins to complex systems that contain more than 20 proteins. Type II and type V are 
sec-dependent secretion systems that require a sec pathway for transport of proteins, while 
type I and type III are sec-independent secretion systems. Even though these systems 
transport various proteins and substrates, the research is mainly focused on transport of 
virulence proteins which is important for the pathogenicity.  
 Various secretion systems in gram-negative bacteria are explained below with a 
special emphasis on the type III secretion system (T3SS) and type VI secretion system 
(T6SS). We have studied the structure and function of GrlR, a regulator protein in T3SS 
and EvpC, which is a secreted protein in T6SS. The details of our studies on T3SS are 




Figure 1.2. Type I–V secretion systems in gram-negative bacteria. Type I, type III and 
type IV SSs (left) are believed to transport proteins in one step from the bacterial cytosol 
to the bacterial cell surface and external medium. In the case of type III and type IV SSs, 
the proteins are transported from the bacterial cytoplasm to the target cell cytosol. One 
exception for type IV is the pertussis toxin, which is secreted in two steps and released 
into the extracellular medium. This exception is represented by the dotted arrow, which 
connects Sec and the type IV SS. Type II and type V SSs transport proteins in two steps. 
In that case, proteins are first transported to the periplasm via the Sec or Tat system before 
reaching the cell surface. Type Va is a putative autotransporter, indicating that the C-
terminus of the protein forms the outer-membrane channel (cylinder) whereas the N-
terminus (pink line) is exposed to the surface or released by proteolytic cleavage 
(scissors). In this figure C means bacterial cytoplasm, IM means bacterial inner 
membrane, P stands for bacterial periplasm; OM means bacterial outer membrane, ECM 
means extracellular milieu and PM (brown zone) stands for host cell plasma membrane. 
Where appropriate, coupling of ATP hydrolysis to transport is highlighted. Arrows 










1.4. Sec System 
 
 The Sec system is a conserved secretion system which is found in the plasma 
membrane of bacteria and Archaea (SecY), and in the endoplasmic reticulum of 
eukaryotic cells (Sec61) (Pohlschroder et al., 2005). The Sec protein complex is capable 
of conducting large substrates through membrane without the loss of small molecules. 
 In bacteria, this system consists of three membrane protein components: SecY, 
SecE and SecG of the protein channel, and SecA - a soluble ATPase (Chen and Tai, 
1985).  Secretion via the Sec pathway generally requires the presence of an N-terminal 
signal peptide on the secreted protein. The motor protein ATPase (SecA) pushes proteins 
across the channel (Brundage et al., 1990). It also requires another protein, SecB, to 
prevent premature protein folding and to aid the proteins to the membrane (Weiss et al., 
1988).  
 The SecYEG translocon sorts integral membrane proteins to their final destination 
and it also transports periplasmic and outer membrane proteins across the membrane. The 
Sec translocon is able to handle different types of proteins, in the unfolded form (Holland 
2004). SecY protein forms the channel pore and it also forms a complex with SecE and 
SecG; in addition, it proofreads the signal sequences bound to SecA. SecE has been 
proposed to form a clamp around the SecY domains, in order to maintain the channel 
closed in the resting state (van den Berg et al., 2004). SecG is proposed to facilitate the 





1.5. Type I Secretion System (T1SS) 
 T1SS is a sec-independent secretion system (Hueck, 1998). It has a simple 
assembly of an inner membrane transport ATPase or an ATP-binding cassette (ABC) 
transporter protein located within the inner membrane, a periplasmic protein, and an outer 
membrane protein that forms the secretion pore. The outer membrane protein is 
characterized by the presence of 12 β sheets that assemble into a β barrel, which forms the 
outer membrane pore (Schmidt and Hensel, 2004).  
 The ABC-transporter protein has multiple functions, like substrate recognition and 
specificity determination and it also provides energy for protein secretion, through ATP 
hydrolysis (Binet and Wandersman, 1995). ABC proteins are believed to form 
homodimers and they are dedicated to the transport of a specific substrate protein. 
However, the outer membrane proteins can interact with different ABC transporters to 
secrete a variety of target proteins. The ABC transporter protein is linked to a membrane 
fusion protein (MFP) that extends from the periplasm and forms a continuous channel to 
the surface with an outer membrane protein. T1SS allows the secretion of a wide range of 
substrates (proteinaceous and non-proteinaceous) from the cytoplasm to the extracellular 
space in a single step, without a stable periplasmic intermediate (Gerlach and Hensel, 
2007). The proteins that are transported through T1SS can be as big as 800 kDa (Holland 
et al., 2005) and these proteins carry signal peptide sequences of about 50 amino acids 






1.6. Type II Secretion System (T2SS) 
 
 
 T2SS is a sec-dependent protein transport system. This secretion system has two 
steps; in the first step a protein is transported across the cytoplasmic membrane into the 
periplasm. This transport is made with the help of the sec system. In this step, the protein 
may be in an unfolded form. The typical N-terminal signal peptides in the protein help to 
identify the sec system during this step (Voulhoux et al., 2001; de Keyzer et al., 2003; 
Palmer et al., 2005). In the second step, signal proteases cleave off the signal peptides and 
the protein folds properly and the folded protein is transported through the outer 
membrane.  
 V. cholerae, E. coli, Legionella pneumophila, Yersinia enterocolitica, P. 
aeruginosa, Burkholderia pseudomallei, Erwinia chrysanthemi and Xanthomonas 
campestris are some of the bacterial species which use T2SS. T2SS consists of 12 to 15 
proteins. It spans across the cytoplasm, periplasm and outer membrane. T2SS consists of 
three subunits, an inner membrane platform, a periplasmic pseudopilus and an outer 
membrane complex (Filloux, 2004; Johnson et al., 2006). This is the most common 
secretion system found in pathogenic and non-pathogenic bacteria. Genes encoding T2SS 
are present in the core gene set. Apart from virulence proteins, T2SS also transports other 
important proteins, like toxins, proteases, lipases and cellulases. Even though T2SSs is 
well conserved, the components of the system are highly species-specific (Groot et al., 









Figure 1.3. Model of pilus-mediated secretion via the T2SS in V. cholerae with structures 
of EpsE (red), EpsL (blue), EpsM (green) and the T2S:GT homolog PulG (light purple). 
Once assembled in the periplasmic compartment, cholera toxin (AB5, dark purple and 
yellow) is targeted to the T2S machinery and transported across the outer membrane to the 
extracellular environment. The ATPase EpsE (red) is shown in this model as a hexameric 
ring associating with the inner membrane via its interaction with EpsL (blue). A ribbon 
structure of N-terminally truncated, monomeric, EpsE alone is shown in red and the 
structure of the β-sheet-rich cytoplasmic domain of EpsL is shown in blue. The X-ray 
structure of the cytoplasmic domain of EpsL co-purified and crystallized with the N-
terminal 96 residues of EpsE is also depicted in blue and red, respectively. EpsM (green) 
crystallized as a dimer and is capable of interacting with and localizing EpsL to the cell 
poles in V. cholerae. The X-ray structure of the T2S:GT homolog from Klebsiella oxytoca, 
PulG (light purple), shows that it has a structure similar to the type IV pilins; a conserved 
α-helix followed by four β-strands arranged in a globular domain. Once the PulG 
monomers assemble to form a pilus-like structure, they may act as a piston to push the 
toxin and other secreted proteins out of the periplasm through the outer membrane 
secretin, T2S:DQ. T2S:CP interacts with T2S:DQ in the outer membrane and has been 
shown to stabilize T2S:LY and T2S:MZ in the inner membrane. Only the core components 
of the T2S system are shown in this model as the T2S:A, T2S:B and T2S:S proteins are 
not present in every species.  








1.7. Type III Secretion System (T3SS) 
 
 T3SS is a complex secretion system, which consists of more than 20 proteins. This 
secretion system has the capability to inject effector proteins directly into the host cell 
(Hueck, 1998). Many of the T3SS proteins are conserved in various pathogens. Both plant 
and animal pathogens use T3SS for injecting their virulence proteins.  Although the T3SS 
apparatus proteins are conserved among various pathogens, they inject different types of 
effector/virulence proteins into the hosts. 
 T3SS mainly consists of three groups of proteins: the first group comprise the 
secretion system apparatus and are known as structural proteins, the second group which 
helps in the translocation of proteins are known as translocators and the third group which 
are transported using the T3SS are known as effectors (Coburn et al., 2007). T3SS does 
not have an N-terminal signal sequence which is involved in the secretion process. A 
secreted protein also needs chaperones to prevent its premature interaction with other 
proteins. T3SS-associated ATPases play a major role in protein secretion, substrate 
recognition and chaperone release from T3SS proteins as well as unfolding of type III 
secreted proteins (Akeda and Galan, 2005). The regulation of protein secretion by contact 
with host surface is also reported in some species.  
 The T3SS system consists of two ring-like structures and one needle complex, 
which protrudes out of the bacterial surface (Fig. 1.4). It starts from the bacterial 
cytoplasm and traverses the inner bacterial membrane, periplasm, outer bacterial 
membrane, extracellular space and the host cellular membrane into the host cytoplasm. 
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The needle complex is the main organelle outside bacteria that protrudes from the 
bacterial surface and has a central channel with a diameter of about 28Å (Marlovits et al., 
2004). In S. enterica, the needle complex is formed by a base and a filamentous needle, 
composed of a single protein, PrgI, that projects ~50 nm from the bacterial surface 
(Kubori et al., 1998). In addition to the chaperone-binding domain, specific elements that 
are required for secretion are also localized in the N-terminus of the secreted protein 
(Lloyd et al., 2001). 
So far more than twenty five species of bacteria are reported to have functional T3SS 
(Cornelis, 2006). The characteristics of certain pathogenic bacteria, which use T3SS for 







Figure 1.4. The type three secretion system (T3SS). This general diagram shows the 
passage of an effector protein from its production site in the bacterial cytoplasm, through 
the structural needle, and into the host cell cytoplasm. A macromolecular needle is formed 
through the assembly of T3SS structural proteins, and is approximately 80 nm long. It 
extends from the bacterial cytoplasm, through the Gram-negative envelope to the 
extracellular space, where the tip inserts into the target cell membrane. Protein effectors 
from the microbe are then injected into the host cytoplasm. In this figure IM means inner 
membrane, PP means periplasm, OM means outer membrane and HCM means host cell 








Table 1.1.  The characteristics of certain pathogenic bacteria, which use T3SS for delivering the effector proteins. (This table is 
adapted from Coburn et al., 2007) 
Pathogen T3SS components 
Structural proteins/  
Translocators                                                                     Effectors 
Hosts Relationship with hosts Diseases caused by agent 
 
 




Ysc injectisome, YopB, 
YopD, LcrV 
YopH, -E, -T, and -O and 
YpkA, -P/J, and -M 
Humans, cattle, 
rodents, 
fleas (Y. pestis) 
Pathogen Plague (bubonic, pneumonic, and 
septicemic)(Y. pestis), enterocolitis and  
mesenteric lymphadenitis 
(Y. enterocolitica and Y. pseudotuberculosis) 
Salmonella enterica serovars 
(Typhimurium, Typhi, 
Paratyphi, Sendai, Dublin, & 
Choleraesuis) 
SPI1, PrgK, PrgH, InvG (ring base), PrgI 
(needle) & SipB/C/D 
(putativetranslocators) SPI2, Ssa proteins 
(apparatus), Ssc 
proteins (effector chaperones), 
SsrAB(regulators), and 
SseB/C/D(translocators) 
SPI1, AvrA, SipA/B/C/D, 
SlrP, SseK, SopA/B/D/E/E & 
SptP; SPI2, SpiC, SseF/G/I/J, 
SlrP,SspH1/H2SifA, SifB, 




cows, and pigs 
Pathogen (in humans, 
rodents, 
cows& pigs), innocuous 
carriage (in chickens and 
some 
human cases) 
Enterocolitis in humans and typhlitis and 
typhoid-like disease in mice (serovar 
Typhimurium), enteric fever in humans 
(serovars Typhi, Paratyphi, and Sendai), 
intestinal inflammation and bacteremia in 
cows (serovar Dublin), septicemia in pigs 
(serovar Choleraesuis) 
EPEC/EHEC EspA/B/D (translocators) Tir, Map, Nle’s, EspF/G, Cif, 
Orf3 
Humans, cows, calves Pathogen (in humans and 
calves), innocuous carriage ( 
cows) 
Intestinal inflammation and bloody diarrhea 
(EPEC/EHEC), possibility of renal failure and 
septic shock (EHEC) 
Shigella species (S. dysenteriae, S. 
flexneri, S. boydii, & S. sonnei 
[multiple serotypes])  
 
Mxi/Spa (apparatus), IpaB/C 
(translocators), IpgC 
(IpaB/C chaperone)  
 
IpaA/B, C terminus of IpaC, 
VirA, IpaH, Osp’s, IpgB1 
Humans (only known 
reservoir) 
Pathogen Bacillary dysentery (shigellosis), 
sporadic dysentery pandemics 
(S. dysenteriae) 
Bordetella species (B. pertussis, 
B. parapertussis, and 
B. bronchiseptica) 
BopB, BopD (potential 
translocators) 
BopC Humans, dogs, pigs Pathogen Whooping cough (B. pertussis and B. 
parapertussis[milder with B. parapertussis]), 
kennel cough in dogs, atrophic rhinitis in 
swine, possible respiratory illness in humans 
(B. bronchiseptica) 
Pseudomonas aeruginosa PopB and PopD 
(translocators), PcrV, 
SpcU (chaperon for 
ExoU) 
ExoS, ExoT, ExoU, ExoY Part of normal flora in 
up 
to 20% of humans, 





Pneumonia (common cause of hospital-
acquired pneumonia and occasionally of 
community-acquired pneumonia), chronic 
airway infection in cystic fibrosis, urinary tract 
infections in long-term care facilities, various 
other clinical infections (e.g., endocarditis) in 
immunocompromised patients 








T3SS1 (V. parahaemolyticus) 
T3SS2 
(V.parahaemolyticus and V. cholerae) 




Human pathogens Noninflammatory secretory diarrhea (V. 
cholerae), inflammatory diarrhea with 
potential systemic spread(V.parahaemolyticus) 
Chlamydia species YscN (ATPase), LcrH1 and-2 and SycE 
(chaperones), LcrE (structural “lid”) 
IncA and additional Inc 
proteins, Cpn0909, Cpn1020 
Obligate intra-cellular 
pathogens, infectious 




C. pneumoniae), bird 
pathogen (C. psittaci) 
Sexually transmitted infection (C. 
trachomatis), pneumonia 




 In 2008, Strynadka and co-workers modeled a type III secretion system apparatus 
by assembling the three-dimensional structures (X-ray and NMR) and cryo EM structures 





Figure 1.5. Overall architecture of the Type III secretion apparatus (T3SA). Crystal 
structures of known individual protein components [accession codes: LcrV(1r6f), MxiH 
(2v6l), MixM (1y9l), EscJ (1yj7) and EscN (2obl)] have been docked into a cryo EM Map 
of the S.enterica serovar typhimurium needle complex (3D EM Database accession code 
emd1100) alongside a model displaying the morphology of the T3SA. The predicted 
dimensions and locations of the three lipid bilayers and peptidoglycan layer are illustrated. 




 Major studies on T3SS were conducted in Yersinia (Cornelis, 1987), Shigella 
(Lindberg and Pal, 1993), Salmonella (Pang et al., 1995), E. coli (Donnenberg and 
Kapper, 1992), Pseudomonas and various plant pathogens like Erwinia, Pseudomonas, 
Ralstonia, and Xanthomonas species (Bonas, 1994). A brief description of some of the 
major pathogenic bacterial species with T3SS is given below. 
 
1.7.1 Salmonella species 
            Salmonella contain two T3SSs, encoded by two PAIs, namely SPI-1 and SPI-2. 
These two T3SSs play different roles during pathogenesis. SPI-1 is required for initial 
penetration of the intestinal mucosa and SPI-2 is necessary for subsequent stages of 
infection. Broad spectrums of disease are caused by Salmonella spp. including 
gastroenteritis, bacteremia, and enteric fever. S. enterica serovar typhi causes typhoid 
fever in humans (Pang et al., 1995).  S. enterica and S. enteritidis are major causative 
agents of food poisoning (Miller et al., 1995).  
 Salmonella species survive and replicate inside the vacuole and use macrophages 
as vehicles to disseminate via the host lymphoid system. The bacteria accumulate and 
massively replicate in the liver, spleen and bone marrow and cause organ failure and 
bacterial sepsis, leading to death within four to six days of infection. The ability to survive 
and replicate in phagocytes is therefore thought to be an essential virulence determinant of 
Salmonella that cause systemic infection (Fields et al., 1986; Libby et al., 1994; Schmitt 





1.7.2. Yersinia species 
 Yersinia pestis, Y. enterocolitica and Y. pseudotuberculosis are the three Yersinia 
species which attack human beings and rodents. Y. pestis, which is the causative organism 
for bubonic plague, multiplies in regional lymph nodes and gets disseminated via the 
lymphatic system. Normally, it leads to the death of hosts within two to three days of 
infection.  
 Y. enterocolitica causes a broad range of gastrointestinal syndromes in humans. Y. 
pseudotuberculosis, which is the least pathogenic of the three species for humans, rarely 
causes gastroenteritis (Cornelis et al., 1987). Y. enterocolitica and Y. pseudotuberculosis 
usually enter their hosts through oral infections. All the three species have the ability to 
resist the primary immune response of hosts (Burrows and Bacon, 1956). These pathogens 
are present mainly in extracellular regions (Hanski et al., 1989; Hanski et al., 1991). In 
Yersinia species, T3SS is responsible for injecting a number of virulence proteins, namely 
YopE, YopH, YopM and YpkA (Leung et al., 1990; Rosqvist et al., 1990; 1991; Galyov et 
al., 1994) into host cells. These proteins subvert the host signal transduction pathway so that 
the primary immune response is blocked, thus facilitating bacterial infection. 
1.7.3. S. flexneri 
Shigella species is responsible for causing diarrheal diseases including bloody diarrhea 
(Maurelli and Sansonetti, 1988; Lindberg and Pal, 1993). They are mainly present in 
intracellular regions in host. An important process that is needed for Shigella infection is the 
invasion of colonic mucosa (Takeuchi et al., 1968). T3SS secretes proteins such as, IpaA, 
IpaB, IpaC, and IpaD which are directly involved in the above process (High et al., 1992; 
Menard et al., 1993).  
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   Binding of the IpaB and IpaC proteins to a5b1 integrin, which is a cell adhesion 
molecule on the target cell, may be the primary signal that causes membrane ruffles, finally 
leading to bacterial internalization (Watarai et al., 1996). Membrane ruffling also involves 
localized accumulation of a variety of cytoskeletal and signal transduction molecules like 
actin and several actin-binding proteins at the site of bacterial attachment. After 
internalization, the bacteria lyse the phagocytic membrane and gain access to the cytoplasm 
(Sansonetti et al., 1986). In macrophages, S. flexneri induces apoptosis after escape from the 
phagosome (Zychlinsky et al., 1992; Thirumalai et al., 1997). Like invasion of epithelial 
cells, the ability to lyse the endocytic vacuole and to induce apoptosis in macrophages 
depends on the S. flexneri T3SS. All the three T3SS secreted Ipa proteins are necessary for 
vacuolar lysis (High et al., 1992, Menard et al., 1993), while IpaB is specifically involved in 
induction of apoptosis (Zychlinsky et al., 1994).   
 
1.7.4. P. aeruginosa 
P. aeruginosa is an opportunistic pathogen which is capable of infecting immuno-
compromised individuals, including patients with extensive burns or wounds, cystic fibrosis, 
and leukemia (Bodey et al., 1983). T3SS is involved in the secretion of two major virulence 
proteins, exoenzyme S (ExoS) and exoenzyme T (ExoT) (Coburn, 1992) in P. aeruginosa 
(Nicas et al., 1985; Frank, 1997; Yahr et al., 1996). These proteins have ADP ribosyl 
transferase activity (Iglewski et al., 1978) and they target the GTP-binding family of 
proteins in eukaryotes (Coburn, 1992). ExoS is associated with epithelial cell damage and 
dissemination of P. aeruginosa within infected hosts (Nicas et al., 1985; Apodaca et al., 
20 
 
1995; Kang et al., 1997). Some of the P. aeruginosa T3SS virulence proteins are similar to 
those in Yersinia spp (Frithz-Lindsten et al., 1997). 
One of the hallmarks of Pseudomonas infection is epithelial injury in infected lungs. Lung 
pathology in murine infection models requires a functional cytotoxin, ExoU, which is 
translocated by the Pseudomonas T3SS (Finck-Barbancon et al., 1997). Cytotoxicity 
induced by ExoU occurs independently of other T3SS effectors and appears to be due to 
phospholipase activity. The translocation of active ExoU results in destabilization and 
destruction of intracellular membranes, which in turn causes necrosis and correlates with a 
variety of clinical parameters of disease in infection models, including transudation into 
alveoli, interstitial pathology, and mortality (Finck-Barbancon et al., 1997; 2001; Sato et al., 
2003). 
1.7.5. Pathogenic E. coli 
 E. coli belongs to the family Enterobacteriaceae. Most of the E. coli strains are 
harmless and are found in the intestines of mammals. The harmless strains are part of the 
normal flora of the gut, and can help their hosts by producing vitamin K2, or by preventing 
the establishment of pathogenic bacteria within the intestine. 
 However, certain strains like Enterohemorrhagic E. coli (EHEC), Enteropathogenic E. coli 
(EPEC), Enterotoxigenic E. coli (ETEC), Enteroinvasive E. coli (EIEC) and 
Enteroaggregative E. coli (EAEC), are virulent and cause a wide variety of diseases ranging 
from diarrhea to hemolytic uremic syndrome. T3SS is widely studied in the EHEC and 
EPEC strains of E coli. In this thesis (Chapter 2), the structure and function of GrlR, a T3SS 




 1.7.5.1. Enterohemorrhagic E. coli (EHEC) 
Enterohemorrhagic E. coli (EHEC) is a pathogenic strain of E. coli. It is a gram-negative 
rod shaped pathogen which causes hemorrhagic colitis, acute bloody diarrhea and 
abdominal cramps. In children, it can cause hemolytic uremic syndrome, a disease 
characterized by acute renal failure, thrombocytopenia, and microangiopathic hemolytic 
anemia (Nataro and Kaper, 1998). The EHEC strain was first reported by Riley (Riley et 
al., 1983) and Karmali (Karmali et al., 1983). EHEC produces Shiga-like toxin, the key 
virulence factor responsible for both hemorrhagic colitis and hemolytic uremic syndrome. 
 EHEC can be transmitted through food and water. Ingestion of contaminated food, 
especially undercooked meat and raw milk is the major cause of EHEC infection 
(outbreaks) (Griffin, 1988). Contaminated vegetables, fruits and tap water are also 
reported to cause EHEC outbreaks (Morgan et al., 1988, Swerdlow et al., 1992).  
 EHEC belongs to the group of diarrheagenic strains of E. coli that include EPEC, EHEC, 
ETEC and EAEC. The term EHEC was originally coined to denote strains that cause 
hemorrhagic colitis and hemolytic uremic syndrome, express Stx, cause attaching and 
effacing (A/E) lesions on epithelial cells, and possess a ~60-Mda plasmid. The major 




Figure 1.6. Genes involved in EHEC pathogenesis. Genes involved in EHEC 
pathogenesis are similar to those implicated for EPEC, except for the presence of the Stx-
encoding phage on the EHEC chromosome and the presence of the characteristic EHEC 
60-Mda plasmid instead of the EAF plasmid of EPEC. The EHEC plasmid is known to 
encode the enterohemolysin (ehx) as well as a fimbrial antigen potentially involved in 













1.7.5.2. Enteropathogenic E. coli 
EHEC, EPEC and mouse pathogen Citrobacter rodentium are the three bacterial species 
that have the locus of enterocyte effacement (LEE). The genes encoding the T3SS in all 
the above species are located in LEE and they are homologous. The studies on EPEC 
T3SS can be extended to the other two species also. 
 EPEC and EHEC strains are distinguished from other E. coli strains by their ability 
to inflict characteristic lesions in small intestine enterocytes, with gross cytoskeletal 
damage and loss of brush border microvilli (Staley et al., 1969). After the initial 
adherence to epithelia, these pathogens attach intimately to the epithelial cell surface and 
cause effacement of microvilli beneath the bacteria, resulting in characteristic attaching 
and effacing (A/E) lesions (Moon et al., 1983). In the region of contact between bacteria 
and the epithelial cell surface, cup-like pseudopod structures appears which form 
progressively elongating pedestals carrying individual bacteria on their tops (Rosenshine 
et al., 1996).  
 Intimate attachment, effacing of microvilli and formation of pedestals require a 
bacterial adhesin (called intimin) and EPEC type III secretion. Intimin is not secreted by 
the type III secretion pathway, but the encoding gene (eaeA) is located within the gene 
cluster that encodes EPEC T3SS (Donnenberg and Kaper, 1991; Jerse et al., 1990; 1991), 
and intimin functions in tandem with type III secretion in pedestal and A/E lesion 
formation. Intimin specifically binds to Tir (translocated intimin receptor), which is 
secreted by T3SS and inserted into the eukaryotic membrane (Kenny et al., 1997). EspA 
and EspB are the other two T3SS secreted proteins which may be translocated into host 
cytosol (Donnenberg et al., 1993; Kenny and Finlay, 1995; Kenny et al., 1996). These 
24 
 
proteins are required for the membrane insertion of Tir (Kenny et al., 1997). Intimin 
directly binds with Tir, thus showing that EPEC strains transfer their own receptor for 
intimate attachment into eukaryotic cells. Concomitant with pedestal formation, adherent 
EPEC strains induce tyrosine phosphorylation of several proteins in the eukaryotic cell, 
including Hp90/Tir (Rosenshine et al., 1992; 1996) and phospholipase C-g1 (Kenny and 
Finlay, 1997). The tyrosine phosphorylation and host cell signaling also depend on the 
type III secretion of EspA, EspB, and EspC (Rosenshine et al., 1992; Foubister et al., 
1994; Kenny et al., 1996; Lai et al., 1997).  
1.7.6. Implication of T3SS Proteins in Therapeutics 
Recently, Coburn and co-workers (2007) have reviewed T3SS with special emphasis on 
the diseases caused by these proteins and the recent developments in clinical research. Fig. 
1.7 shows the details of pathological importance of T3SS. The T3SS proteins are targeted 
in different ways for controlling the diseases caused by them. 
 
Figure 1.7. T3SS effector functions of pathophysiologic importance. T3SS effectors have 
been implicated in a variety of critical pathogenic behaviors. These virulence strategies 
have specific consequences in disease pathogenesis in the infected host. (This figure is 




  Antibodies developed against some of the T3SS proteins in Yersinia and Pseudomonas 
were successful in mouse models against septic shock as well as bubonic plague (Frank et 
al., 2002; Goure et al., 2005). Some of the T3SS virulence genes have been targeted for 
vaccine production. In Yersinia, immunization experiments with YscF in the mouse model 
proved that this T3SS protein can be used for prophylactic treatment against bubonic 
plague (Matson et al., 2005; Swietnicki et al., 2005). Studies using T3SS secreted proteins 
have shown that they have the potential to be developed as vaccines for immunizing 
cattle, the major carriers of EHEC pathogens (Potter et al., 2004; van Donkersgoed, 
2005). Possibilities are being explored to develop inhibitors against these proteins and also 
for using these proteins as diagnostic tools (Kauppi et al., 2003; Li et al., 2005).  
T3SS helps gram-negative bacteria to transport a wide variety of proteins (mainly 
virulence proteins) into plant and animal host cells (Hueck, 1998). Recent studies have 
revealed selected T3SS proteins to be potential targets for controlling the diseases that are 
caused by these organisms by specifically attenuating the causative bacterial pathogens 
without affecting the commensal flora. Further developments in this field will eventually 





1.8. Type IV Secretion System (T4SS) 
 T4SSs are able to translocate proteins or complexes of protein and single-stranded 
DNA into a wide variety of recipients, which include bacteria, fungi, plants and 
mammalian cells (Cascales and Christie, 2003). T4SS is  made up of a complex structure 
of at least 10 subunits and are similar to conjugation systems for the transfer of DNA 
(Christie, 2001). Based on sequence similarities, T4SS is believed to have evolved from 
bacterial conjugation machineries (Cascales and Christie, 2003). T4SS in Agrobacterium 
tumefaciens mediates the translocation of a DNA-protein complex into plant cells, a 
process required for induction of tumor formation in plants. This T4SS is distinct from the 
T4SS of pathogens of humans and animals that translocate only proteins.  Based on 
sequence homology, T4SSs are categorized into two subclasses: type IVA (T4ASS) and 
type IVB (T4BSS) (Christie and Vogel, 2000). The T-DNA transfer system of A. 
tumefaciens is the prototypical T4ASS (Burns, 1999). 
 T4ASS plays a major role in several human bacterial pathogens. The pertussis 
toxin of Bordetella pertussis is secreted in a contact independent manner, while CagA of 
Helicobacter pylori is a translocated T4SS effector protein that induces inflammatory 
responses and cytoskeletal alterations in the host cell. T4ASS has also been identified in 
Brucella spp. and Bartonella henselae, and the translocated effectors have central 
functions in the intracellular lifestyle of these pathogens (Backert and Meyer, 2006). 
T4BSS is present in Legionella pneumophila which requires 26 dot (defect in organelle 
trafficking) and icm (intracellular multiplication) genes for pathogenesis (Sexton and 
Vogel, 2002; Segal et al., 2005).  
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1.9. Type V Secretion System (T5SS) 
T5SS is one of the simplest protein secretion systems. This system is divided into three 
types: those secreted via an auto-transporter system (type Va or AT-1), the two-partner 
secretion pathway (type Vb), and the type Vc system (also termed AT-2) (Desvaux et al., 
2004).  The proteins secreted through these pathways are almost similar in their modes of 
biogenesis and their primary structures also show similarity (Henderson et al., 2004). Fig. 
1.8 provides a schematic overview of the type V secretion pathways. T5SSs are sec-
dependent systems. In this system, transport of proteins takes place through a two-step 
process as detailed below. 
 In T5SS the pre-protein consists of the following components:  signal sequence, 
the passenger domain, linker region and β-strand. The signal sequence which is present at 
the N-terminus guides the protein to the sec machinery at the inner membrane. Once the 
protein reaches the periplasm with the help of the sec system, the N-terminal signal 
sequence gets cleaved off. Upon contact with the outer membrane, the β-strand region is 
converted into a β-barrel, which makes a pore in the outer membrane through which the 
passenger domain can be secreted. Once it is secreted across the outer membrane, the 
passenger domain gets cleaved off from the other domains. There are various passenger 
domains secreted by T5SS (e.g., the immunoglobulin G proteases and the VacA toxin). 
Examples of T5SS encoded by PAI are LPA and the EspC PAI of the pathogenic E. coli, 




Figure 1.8. Schematic overview of T5SSs. The secretion pathway of the autotransporter 
proteins (type Va) is depicted at the bottom left of the diagram, the two-partner system 
(type Vb) is depicted in the center of the diagram, and the type Vc or AT-2 family is 
depicted on the right. The four functional domains of the proteins are shown: the signal 
sequence, the passenger domain, the linker region, and the β-domain. The autotransporter 
polyproteins are synthesized and generally exported through the cytoplasmic membrane 
via the Sec machinery. Interestingly, effector proteins with an unusual extended signal 
sequence, which purportedly mediates Srp-dependent export, are found in all three 
categories of type V secretion. Once through the inner membrane, the signal sequence is 
cleaved and the β-domain inserts into the outer membrane in a biophysically favored β-
barrel structure that forms a pore in the outer membrane. After formation of the β-barrel, 
the passenger domain inserts into the pore and is translocated to the bacterial cell surface, 
where it may or may not undergo further processing. (This figure is adapted from 








1.10. Type VI Secretion System (T6SS) 
 T6SS is a protein secretion system that has been recently discovered in gram-
negative bacteria. The components of T6SS vary among different organisms. The genes 
that are responsible for T6SS are located in the IAHP (IcmF Associated Homologous 
Protein) cluster. This secretion system is reported mainly in the following species, viz, 
Rhizobium leguminosarum, V. cholera, S. enterica, Edwardsiella tarda and P. aeruginosa.  
  The identification of the IAHP gene cluster was first reported in 2003 (Das and 
Chaudhuri, 2003). They identified a gene cluster containing 15 genes surrounding the 
intra cellular multiplication genes (IcmF) and were named IcmF associated homologous 
protein clusters (IAHP). IcmF is reported to be a part of T4SS and it is extensively studied 
in L. pneumophila, where it plays a role in host cell killing and multiplication (Purcell and 
Shuman, 1998, Segal et al., 1998). By genome analysis, the IAHP gene cluster was also 
found to be present in the following gram-negative bacteria: E. coli, Y. pestis, R. 
leguminosarum, P. aeruginosa, Mesorhizobium loti, S. enterica and A. tumefaciens (Das 
and Chaudhuri, 2003). Later studies on IAHP proteins in R. leguminosarum confirmed 
that they play an important role in temperature-dependent protein secretion (Bladergroen 
et al., 2003). Recent studies from our lab have shown that this particular system is also 
present in E. tarda and that they might play an important role in pathogenesis of this 
organism (Rao et al., 2004; Zheng et al., 2005).  
 T6SS gained its importance from recent studies by Mekalanos and co-workers. 
They identified and described Hcp1 protein, which is secreted using this system (Pukatzki 
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et al., 2006; Mougous et al., 2006). A schematic representation of T6SS is given in Fig. 
1.9. The features of T6SS in different bacteria are shown in Table 1.2. 
 
Figure 1.9. Schematic representation of a T6SS. The ClpV ATPase (orange) may help to 
transport Hcp (yellow) and VgrG (dark green) across the cell envelope. The ‘VgrG’ 
puncturing device (dark green arrows) could be involved either in injecting the C-terminus 
of evolved VgrG (dark green circle) into the eukaryotic cell or in releasing VgrG into the 
milieu or at the bacterial cell surface. Lip (pink) is a putative outer-membrane lipoprotein. 
IcmF (blue) and DotU (red) are inner-membrane proteins. The level of phosphorylation of 
the Fha protein (brown) regulates T6SS activity. In this figure STK (dotted light green) is 
the Ser/Thr kinase, whereas STP (light green) is Ser/ Thr phosphatase. C means bacterial 
cytoplasm, IM means bacterial inner membrane, P stands for bacterial periplasm, OM 
means bacterial outer membrane, ECM means extracellular milieu. PM (brown zone) 
means host cell plasma membrane. (This figure is adapted from Filloux et al., 2008) 
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Table 1.2. Some features of T6SSs in various bacteria 
 
Bacterium  T6SS genes Secreted proteins Putative secreted 
proteins 
Regulatory proteins Notable features 
Burkholderia mallei tss Hcp1, VgrG1 Tssb, TssM VirAG two-component system BMAA1517 (AraC-
type regulator) 
Attenuated virulence in hamsters 
Edwardsiella ictaluri eip    Anti-Eip produced during catfish infection 
Edwardsiella tarda evp EvpC (HcP) 
EvpP  
EvpI 
 EsrB (response regulator, SsrB-like) 
Temperature-dependent 
Attenuated virulence in blue gourami fish 







AggR (AraC-type regulator) 
 
Franciella tularensis igl, pdp, pig  PigG (VgrG-like) MglA master regulator 
Induced in vivo (macrophages) 
Required for intramacrophage growth;  
no ClpV-homologue 





















Two-component system sensor RetS 
Two-component system sensor LadS 




Putative s54 activator (PA1663) 
Stk1/Stp1 S/T kinase-phosphatase 
 
Putative s54 activator (PA2359) 
No S/T kinase-phosphatase or Fha 
Attenuated virulence in rat lung infection; 
anti-Hcp1 produced in CF patients 
Pectobacterium atrosepticum   Hcp-1,  -2, -3, -4, VgrG  Induced by host-plant extract  
Rhizobium leguminosarum Imp RbsB homologue  Temperature-dependent 
 ImpM/ImpN S/T kinase-phosphatase 
No ClpV homologue 
No lipoprotein-encoding gene; signal peptide 
in RbsB; C-terminal extension in DotU 
Salmonella enterica subspecies1 Sci  SciK (Hcp), 
 VgrS (VgrG) 
Induced in vivo (macrophage and 
rabbit ileal loop) 
Response regulator SsrB 
Increased bacterial number in macrophages 
Hypervirulent in mice 
Vibrio cholerae Vas Hcp1, -2, VgrG1, -2, -3  Induced in vivo (rabbit model for cholera) 
RpoN (s54) 
Putative s54 activator (VasH) 
Fha but no S/T kinase-phosphatase 
Attenuated virulence on Dictyostelium and 
macrophages 
VgrG1 covalently cross-links actin 
 
*Regulatory components that control T6SS expression and function have been indicated as well as conditions in which T6SS genes are specifically controlled. 
The role of the putative s54 activator in expression of T6SS genes has not been demonstrated. However, in V. cholerae, a putative s54 activator is required for 
the T6SS-dependent phenotype as well as RpoN (s54). The attenuation or hypervirulence is indicated when it has been observed for at least some of the 
described T6SS mutants. (This table is adapted from Filloux et al., 2008). The three E. tarda secreted proteins EvpC, EvpP and EvpI are also 





 The T6SS secretion system that has been identified in some of the major gram-
negative pathogenic bacteria is described below. 
 
1.10.1. V. cholerae 
 
 The T6SS was characterized in V. cholerae by Das and co-workers (2002). 
They were the first to analyze the IAHP gene cluster in V. cholerae. The work by 
Pukatzki and coworkers (2006) identified the IAHP gene cluster as T6SS. Transposon 
mutagenesis and transposon mapping studies on V. cholera strain V52 identified the 
presence of a cluster of genes known as ‘virulence associate secretion’ (vas) genes. These 
vas genes had homologies with the previously described imp genes from R. 
leguminosarum (Bladergroen et al., 2003). 
 
 Further studies on the vas system revealed that the Hemolysin A co-regulated 
protein (Hcp) (Williams et al., 1996) and VgrG were absent in vas mutants (Pukatzki et 
al., 2006). They also reported that a V. cholerae strain sensitive to Dictyostelium lacks the 
ability to secrete Hcp and VgrG proteins and a similar secretion deficiency was also seen 
in the V52 vas mutants. These results have shown that Dictyostelium resistance is 
dependent on the secretion of the Hcp and VgrG proteins. The proteins VgrG1, VgrG2, 
VgrG3 and Hcp lack an N-terminal signal peptide and this secretion system 






1.10.2. S. enterica 
 
 A complete gene cluster, which is 47 kb long and harbors 37 genes named sci 
(S. enterica centisome 7 genomic island), was described in S. enterica (Folkesson et al., 
2002). Many genes from this cluster may be related to T6SS, especially 9 of the 15 vas 
genes found in V. cholerae. The genes encoding Hcp-like protein (sciK) and a VgrG-like 
protein (vgrS) are present in Sci Island (Table 1.2). An S. enterica mutant, which lacks 
the Sci genomic island, showed decreased ability to enter eukaryotic cells.  
 
1.10.3. P. aeruginosa 
 
 The T6SS gene clusters hsiI, hsiII and hsiIII that are present in P. aeruginosa 
are shown in Table 1.2 (Das and Chaudhuri, 2003). Out of these, HSI-I contributes to P. 
aeruginosa pathogenesis (Mougous et al., 2006). HSI-I genes are normally induced in 
vivo, but they can be induced in vitro by deleting the  retS gene, which codes for a sensor 
protein. This sensor protein is part of an important signaling pathway for chronic 
infections (Goodman et al., 2004). An Hcp-like protein, which is part of the HSI-1 gene 
cluster, was also detected in the supernatant of the retS deletion mutant (Table 1.2) 





1.10.4. Pathogenic E. coli 
 
 In enteroaggregative E. coli (EAEC), two type six secretion systems, EAECSci-I 
and EAECSci-II, have been reported (Dudley et al., 2006). The secretion system 
EAECSci-II consists of a group of proteins from aaiA through aaiP (AggR-activated 
island). These groups of proteins are under the control of the virulence-plasmid-encoded 
AggR (aggregative adherence) transcriptional regulator (Dudley et al., 2006). They 
reported that the aai cluster is involved in the secretion of AaiC, which has no homolog 
in any other T6SS. But this protein is around 18-19 kDa in size and does not contain a 
signal peptide, a feature which is common in other T6SS secreted proteins, like EvpP 
(T6SS protein from E. tarda). The aai cluster is located in an EAEC pathogenicity island. 
The second T6SS EAECSci-I is independent of AggR and contains 21 genes. In 
EAECSci-I cluster; an hcp-like gene encodes a product that is secreted in a T6SS-
dependent manner. 
 
1.10.5. E. tarda  
 
 E. tarda is a major fish pathogen that causes hemorrhagic septicemia in fish 
(Janda and Abbott, 1993; Plumb, 1993; Thune et al., 1993) and also gastro-, extra- 
intestinal as well as wound infections in humans (Janda and Abbott, 1993). In E. tarda, 
the T6SS cluster was named EVP (Edwardsiella virulence proteins) and contains 16 
genes (Zheng et al., 2005; Zheng & Leung, 2007). Studies in Edwardsiella ictaluri 
identified several genes which are homologous to the ‘imp’ genes in Rhizobium and they 
35 
 
named it as the ‘eip’ genes (Moore et al., 2002). Studies from our lab on E. tarda 
identified EvpC, a homologue of Hcp1 in E. tarda and another protein EvpP with no 
known homology to any of the T6SS proteins (Rao et al., 2004). Our studies have shown 
that 13 genes in the EVP cluster are required for EvpC secretion (Zheng and Leung, 
2007). In E. tarda the deletion of evpB or evpC genes has been shown to reduce the 
replication rates in gourami phagocytes. These deletions also reduced protein secretion 
and virulence of E. tarda in blue gourami fish (Rao et al., 2004). In addition to T6SS, E. 
tarda has T3SS (Rao et al., 2004).  
 T6SS is composed of around 13 to 16 genes in one cluster. These gene clusters 
may vary in the number of components in different organisms. T6SS encodes proteins 
which form part of the secretion apparatus as well as virulence genes. An interesting 
protein is Hcp1 in P. aeruginosa, which is shown to form hexameric ring-like structures 
(Mougous et al., 2006). In certain species, T6SS is encoded in more than one locus. Since 
this system has been identified very recently, the complete function and characteristics 
are not well established. With the recent spate of developments, T6SS will be well 
studied in the coming years and new target proteins for developing antimicrobial drugs 









1.11. Aim of this thesis 
 For this thesis work, I sought to undertake the structural and functional studies on 
selected key proteins from T3SS and T6SS, to examine the function, regulation, and 
structure of these potential antimicrobial targets. This study will lead to the development 
of drugs to prevent diseases by impairing essential virulence properties. GrlR is a 
regulator protein which is encoded in the locus of enterocyte effacement (LEE). LEE is a 
pathogenicity island that encodes 41 genes, which are responsible for T3SS. We solved 
the structure of GrlR, a key regulator of T3SS in EHEC and EPEC. Furthermore, we 
performed structure based functional studies on GrlR and identified the key residues 
responsible for its regulatory function. A detailed description of the work performed on 
GrlR is given in chapter 2.  From the crystal structure we observed that GrlR has a typical 
lipocalin fold and it might bind with lipids. Subsequently we have crystallized and solved 
the GrlR-lipid complex structure and identified the physiological lipid species binding to 
GrlR using mass spectrometry methods. Isothermal titration calorimetry experiments 
were also performed to identify the interaction of GrlR with lipids. The details of GrlR-
lipid interaction studies are presented in chapter 3. In addition, we have undertaken the 
structural and functional studies on EvpC, a T6SS secreted protein, and a putative 
secretion apparatus protein from E. tarda. EvpC is important for the secretion of T6SS 
proteins such as EvpI, EvpP and EvpC itself. Several structure-based mutants were 
generated to identify the key functional residues of EvpC. The details of the structural 














Structure of GrlR and the Implication of its EDED Motif in 
Mediating the Regulation of Type III Secretion System in 





 The enterohemorrhagic E. coli (EHEC) and enteropathogenic E. coli (EPEC) are 
closely related human enteric pathogens (Polotsky et al., 1977). EPEC, EHEC, and the 
mouse pathogen C. rodentium (CR) belong to a group of pathogenic bacteria that are 
defined by their ability to form ‘‘attaching and effacing’’ (A/E) histopathology on 
intestinal epithelia. This histopathology is characterized by localized destruction of apical 
microvilli, followed by intimate adhesion of bacteria to the cell plasma membrane (Paton 
et al., 1998). A major virulence mechanism underlying A/E-causing bacteria is the type 
III secretion system (T3SS) (Caron et al., 2006; Hayward et al., 2006; Spears et al., 
2006).  
 T3SS components and related proteins are encoded by 41 genes organized in five 
major operons, LEE1 through LEE5, and several additional transcriptional units, all 
clustered in the locus of enterocyte effacement (LEE) (Fig. 2.1) (Clarke et al., 2003). 
Under repressive conditions, the entire LEE is silenced by the histone-like nucleoid 
structuring protein (H-NS). Activation of most LEE promoters is dependent on Ler, an H-
NS paralogue encoded by LEE1, which functions as anti–H-NS to alleviate the H-NS–
mediated silencing of most of the LEE promoters (Friedberg et al., 1999; Mellies et al., 
1999; Sperandio et al., 2000; Sanchez-SanMartin et al., 2001). Therefore, controlling the 
activity of the LEE1 promoter (PLEE1) is critical for initiating a cascade that mediates 
the expression of all of the LEE genes. GrlA and GrlR are two LEE-encoded regulators 
that are required to optimize PLEE1 activity (Barba et al., 2005). These two proteins 
from EPEC and EHEC, respectively, exhibit about 98% identities. GrlA acts as a positive 
regulator for PLEE1; moreover, GrlA and Ler form a positive transcriptional regulatory 
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Figure 2.1. Locus of enterocyte effacement (LEE). LEE contains 41 genes and encodes 
proteins for T3SS. This figure is adapted from Deng et al., 2004 
 
 
 It is suggested that in order to prevent the detrimental accumulation of Ler, the 
Ler–GrlA feedback loop is negatively modulated by two checkpoints: (1) When Ler 
reaches the threshold concentration, it represses ler transcription (Berdichevsky et al., 
2005). (2) GrlR, a negative regulator of ler expression (Deng et al., 2004; Lio and Syu, 
2004), might act as anti-GrlA to establish an additional checkpoint that down-regulates 
the feedback loop, setting it back to the steady-state level(Fig. 2.2). In agreement with 
this hypothesis, GrlR interacts with itself and also with GrlA to form a macromolecular 
assembly in the cytoplasm of AE pathogens (Creasey et al., 2003). It has been proposed 
that GrlR conveys a negative regulation through its interaction with GrlA and that this 
hetero-complex is functionally relevant (Barba et al., 2005; Creasey et al., 2003). The 
literature search and sequence analysis indicated the presence of a helix-turn-helix, a 
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DNA recognition motif, at the N-terminus of GrlA (Deng et al., 2004), and hence only 
the C-terminal region may interact with GrlR. 
 
 
Figure 2.2. Model for the regulation of LEE genes in A/E pathogens. Ler positively 
regulates LEE gene expression by counteracting the H-NS-mediated repression of LEE 
gene promoters. The expression of ler is tightly regulated by specific regulators, such as 
GrlA, GrlR, and PerC, as well as by global regulators, such as IHF, Fis, BipA, EtrA, 
EivF, and QseA. Appropriate levels of ler expression are maintained by a positive 
regulatory loop formed by Ler and GrlA, which could be negatively modulated by GrlR 
through a mechanism that is still not well understood or by the ability of Ler to negatively 
autoregulate its own expression. 
This figure is adapted from Barba et al., 2005.   
   
 Here, we report the crystal structure of GrlR from EHEC refined up to 1.9 Å 
resolution as well as structure-based functional studies on GrlR. GrlR has a typical β-
barrel fold consisting of an internal hydrophobic cavity with a plug-like loop on one side 
of the barrel. Structure-based site-directed mutagenesis targeting the surface residues of 
GrlR showed that these residues are crucial for the ability of GrlR to bind GrlA and to 
carry out its regulatory function. In vitro and in vivo experiments further confirmed the 
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vital role of these residues for the regulatory function of GrlR. Our finding represents a 
novel regulatory mechanism in the T3SS of pathogenic bacteria. 
 
2.2. Materials and Methods 
2.2.1. Plasmid and strain construction 
  The bacterial stains and plasmids used in this study are listed in Table 2.1. The 
intact grlR gene was PCR amplified from the EHEC EDL933 chromosomal DNA and 
cloned into a derivative of the pET vector (pETM32) (Novagen) or pSA10 vector. The 
residues targeted for mutation were substituted with alanine. The pGEX-grlA construct 
was prepared by amplifying grlA from the EHEC EDL933 chromosomal DNA and 
cloning into the pGEX-4T1 vector (Amersham Biosciences). The construction of 
pGY2Ler was as follows. The bla gene in the suicide plasmid pGP704 (Donnenberg and 
Kaper, 1991) was replaced by tetAR, and the gfp+ gene (Hautefort et al., 2003) was 
cloned into the XbaI and SmaI sites generating pGY2. A fragment containing PLEE1-ler 
(the regulatory region of LEE1 and the first gene in LEE1-ler) was amplified by PCR, 
digested with BamHI and XbaI, and cloned into pGY2 digested with BglII and XbaI, 
generating pGY2Ler, in which gfp+ is transcriptionally fused to ler. pGY2Ler was 
introduced into E. coli SM10 kpir, which was further introduced into EPEC by mating. A 
trans-conjugant KanS TetR StrepR colony containing an integration of pGY2Ler into the 
EPEC chromosome was selected to form transcriptional fusion of the LEE1 regulatory 





Table 2.1.  The bacterial strains and plasmids used in this study  
 
Strain or plasmid Description  Reference or source 
Strains    
EDL933  Wild-type EHEC O157:H7, Slt1, Slt2-negative derivative J. Leong 
E2348/69 Prototypic EPEC strain, O127:H6, Smr J. Kaper 
SM10 λpir thi1 thr leu tonA lacY recA supE (RP4-2 Kmr tet::Mu) Iyoda et al.,2004 
GY2455 E2348/69 LEE1reg-ler::gfp+ This study 
Plasmids    
pGEX4T-1 pGEX-2T derivative, Ampr Pharmacia 
pGEXgrlA pGEX4T-1 with grlA fragment This study 
pSA10 pKK177-3 derivative, lacI, Ampr S. Altuvia 
pSAgrlR-6His pSA10 with grlR  fragment and 6His tag at C terminal,  This study 
pSAgrlR E46A 
pSA10 with grlR  fragment and 6His tag at C terminal, substitute 
residue E46 with A This study 
pSAgrlR D47A 
pSA10 with grlR  fragment and 6His tag at C terminal, substitute 
residue D47 with A This study 
pSAgrlR E48A 
pSA10 with grlR  fragment and 6His tag at C terminal, substitute 
residue E48 with A This study 
pSAgrlR D49A 
pSA10 with grlR  fragment and 6His tag at C terminal, substitute 
residue D49 with A This study 
pSAgrlR E46AD47A 
pSA10 with grlR  fragment and 6His tag at C terminal, substitute 
residues E46D47 with AA This study 
pSAgrlR E46AD47AE48A
pSA10 with grlR  fragment and 6His tag at C terminal, substitute 
residues E46D47E48 with AAA This study 
pSAgrlR 
E46AD47AE48AD49A 
pSA10 with grlR  fragment and 6His tag at C terminal, substitute 
residues E46D47E48D49 with AAAA This study 
pGP704 pir-dependent, suicide plasmid Li et al., 2006 
pGY2 A pGP704 derivative in which bla was replaced by tetAR and 
containing gfp+ as transcriptional reporter gene 
This study 
pGY2Ler pGY2 encoding PLEE1-ler transcriptionally fused to the gfp+ gene This study 
 
 
2.2.2. Purification and crystallization.  
 Plasmid DNA was transformed into E. coli BL21 and the cells were grown in 
defined M9 medium (Doublie, 1997) supplemented with 25 mg/l L-SeMet at 37oC to 0.6 
AU at OD600. One liter of culture was induced with 100µl of lM IPTG and continued to 
grow at 20oC overnight. Cells were then harvested by centrifugation and re-suspended in 
40 ml of lysis buffer [50 mM Tris-HCL (pH 7.5), 0.4 M NaCl, 1 mM EDTA, 1% (w/v) 
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Triton X-100, 5% (w/v) glycerol, 10 mM βME, and one tablet of Complete protease 
inhibitors (Roche Diagnostics)]. The protein was purified in three steps using DEAE-
Sepharose (Amersham Pharmacia), Ni-NTA (Qiagen), and gel filtration (Superdex 75, 
Amersham Biosciences) columns, respectively. The His fusion tag was not cleaved. 
Drops containing 1 µl of protein solution (4 mg/ml) and 1 µl of reservoir solution were 
equilibrated in hanging drop vapor diffusion at 21oC. The best crystals were grown from 
25% ethylene glycol, 4% tert-butanol, and 4% trifluoroethanol (Hampton screens 
followed by additive screening), with the protein in 20 mM Tris-HCL (pH 7.5), 200 mM 
NaCl, and 5% (w/v) glycerol. Crystals measuring 0.2 mm in length were grown over a 
course of 3 days and belonged to the orthorhombic space group P212121 with a=43.83Å, 
b=66.09Å, c=83.58Å and contained two molecules in the asymmetric unit. The Matthews 
coefficient is 2.2Å3/Da (Matthews, 1968), giving a solvent content of 45%. The X-ray 
data collection and refinement statistics are given in Table 2.2. 
2.2.3. Data collection, structure solution and refinement.  
 Crystals were cryo-protected in the reservoir solution supplemented with 40% 
ethylene glycol and flash cooled at 100 K. The structure was determined using crystals of 
Se-Met labeled protein by multi-wavelength anomalous dispersion method (Hendrickson, 
1991; Terwilliger and Berendzen, 1997). X-ray diffraction data were collected at beam-
line X12C, Brookhaven National Laboratory (Upton, New York, USA), using a 
Quantum-4 CCD detector (ADSC). Two data sets were collected at wavelengths 
corresponding to the peak and inflection point. All of the data sets were processed with 
HKL2000 (Otwinowski and Minor, 1997). All the eight Se sites in the asymmetric unit 
were located by using the program BnP (Weeks et al., 2002). The phases were further 
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improved by density modification using RESOLVE (Terwilliger, 2003), which gave a 
final overall figure of merit of 0.70. Over 50% of the backbone atoms of the model were 
built by the RESOLVE iteration method. The remaining residues of the molecules were 
added after several cycles of manual model building using O (Jones et al., 1991) and 
followed by refinement using CNS (Brunger et al., 1998). Finally, 342 well-defined 
water molecules were added, and refinement was continued until the R-value converged 
to 0.215 (Rfree = 0.269). The model had good stereochemistry, with all residues falling 
within the allowed regions of the Ramachandran plot (Table 2.2) analyzed by 
PROCHECK (Laskowski et al., 1993). 
 Coordinates of GrlR have been deposited in the Protein Data Bank under 
accession code 2OVS 
2.2.4. In vitro pull-down assay. 
 The plasmid pGEX-grlA was transformed into the E. coli strain BL21 DE3 and 
overexpressed under IPTG induction. The GrlA protein with a GST tag was immobilized 
on GST sepharose beads (Amersham Biosciences) in lyses buffer (20 mM TRIS [pH 7.5], 
200 mM NaCl, 5% glycerol, 10 mM βME ) and washed with wash buffer at various salt 
concentrations (200 mM, 500 mM, and 1 M NaCl) to remove non-specifically bound 
proteins from the beads. The beads with the immobilized GrlA protein were checked for 
purity and quantified using SDS-PAGE and were subsequently used for performing  pull-
down assay studies. Expression and purification of his-tagged GrlR fusion proteins were 
performed as described previously. Equal amounts of GrlR wild-type and mutant proteins 
were added to the GST sepharose beads with bound GrlA and incubated at 4oC for 15 
min (Fig. 2.16). The expression level of GrlR tetra mutant was low compared to that of 
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the wild-type and other mutants. However, an approximately equal amount of tetra 
mutant was used in all of the experiments. The beads were washed twice with wash 
buffer and resolved in 12% SDS-PAGE along with controls.  
 
2.2.5. Analytical ultra centrifugation.  
 The oligomeric state of GrlR was investigated by monitoring its sedimentation 
properties in sedimentation velocity experiments using a Beckman Coulter Optima XL-A 
equipped with absorbance optics. Sedimentation coefficients and molecular masses were 
determined by fitting using both the C(s) method (Schuck, 2000) and Enhanced van 
Holde–Weischet Analysis (Van Holde and Weischet, 1978) as implemented in UltraScan 
7.3 (Demeler et al., 1997; Demeler, 2005). The sedimentation coefficient is given in Fig. 
2. 12 and the velocity data is shown in Fig. 2.13. 
2.2.6. MALDI-TOF MS and MS/MS analysis.  
 Molecular weight determination was carried out with the aid of a Voyager STR 
MALDI-TOF mass spectrometer (Applied Biosystems). For MS/MS analysis, sample 
digestion, desalting, and concentration steps were carried out by using the Montage In-
Gel digestion kits (Millipore). Protein spots were analyzed using an Applied Biosystems 
4700 Proteomics Analyzer MALDI-TOF/TOF (Applied Biosystems). Data processing 
and interpretation was carried out using the GPS Explorer software (Applied Biosystems) 
and database searching was performed using the MASCOT program (Matrix Science). 
The National Center for Biotechnology Information database (www.ncbi.nlm.nih.gov) 




2.2.7. Circular dichroism spectrometry.  
 Far UV spectra (260–190 nm) of GrlR wild-type and mutants were measured 
using a Jasco J810 spectropolarimeter (Jasco) in phosphate buffer (pH 7.5) at room 
temperature using 0.1 cm path length, stoppered cuvettes. A total of three scans were 
recorded and averaged for each spectrum, and the baseline was subtracted. 
 
2.2.8. Extracellular proteins isolation and assay.  
 Extra cellular proteins secretion assay was carried out to study the effect of the 
mutation of EDED residues of GrlR in the secretion of type III secretion system proteins. 
A T3SS protein EspB, a secreted protein of E. coli was taken as a representative marker 
protein for carrying out this experiment. To prepare the secreted protein of EHEC, 
overnight cultures of EHEC strains in LB were diluted at 1:50 into DMEM supplemented 
with 100 mM ampicillin and 0.1 mM IPTG, and incubated for 9 h at 37oC in a 5% (v/v) 
CO2 atmosphere. Bacterial cells were removed from the culture by centrifugation (5500g, 
10 min, 4oC) and the supernatants were collected and passed through a 0.22-µm filter and 
precipitated by 10% TCA as described previously (Li et al., 2004). The extracellular 
proteins were resolved by 12% SDS-PAGE and visualized by staining with coommassie 
blue. Western blot analysis was carried out as described previously (Li et al., 2006), and 
EHEC cells harboring various pSAgrlR plasmids were harvested and resolved by SDS-







2.3.1. Characterization of GrlR 
 The purified SeMet protein was of good quality as indicated by the SDS- PAGE 
(Fig. 2.3), gel filtration (Fig. 2.4) and dynamic light scattering experiments (Fig. 2.5). 
MALDI-TOF mass spectrometry experiments indicated that SelMet was successfully 
incorporated (Fig. 2.6 top and bottom). Diffraction quality crystals of SelMet GrlR are 
shown in Fig. 2.7. 
 
 
Figure 2.3.  SDS-PAGE showing the expression of GrlR. Lane 1 – Flowthrough, Lane 2 – 
Wash1, Lane 3 – Wash  2, Lane4– Protein bound to Ni-NTA beads before elution, Lane5 – 





Figure 2.4. Profile of size-exclusion chromatographic purification of GrlR. The peak around 
32 kDa corresponds to the GrlR protein (Blue colour). The X-axis indicates elution volume in 
mL and the Y-axis indicates the UV absorbance at 280 nm measured in mAU (arbitrary 
units).The elution profile is for the protein injected into an FPLC Hiload 16/60 Superdex75 







Figure 2.5. Dynamic Light Scattering results of purified GrlR. The Polydispersity index, 









Figure 2.6. Mass spectrometry profile of GrlR. Sel-Met labeled GrlR profile (top). 










Figure 2.7. Crystal of SeMetGrlR obtained by vapor batch method with PEG3350 and 
ethylene-glycol as precipitants.  
 
 
2.3.2. Structure of GrlR 
 
 The structure of recombinant GrlR from EHEC was solved by the multi-
wavelength anomalous dispersion method using synchrotron data. The model was refined 
to a final R-factor of 0.215 (Rfree = 0.269) at 1.9 Å resolution (Fig. 2.8) with good 




Figure 2.8. Overall Structure of GrlR with a bound ligand. Ribbon diagram of monomer. 
The β-strands and the random coils/turns are depicted in light and dark green colors, 
respectively. A Triton-X100 molecule is bound in the hydrophobic pore of the eight-
stranded β-barrel. The CPK model of the ligand is shown with oxygen and carbon atoms 
colored in red and grey, respectively. This figure was prepared using Molscript and 















Table 2.2. Crystallographic data and Refinement Statistics 
Data set Peak Inflection High Resolution 
Data collection    
Resolution range (Å) 50 – 2.5 50 – 2.5 50- 1.9Å 
Wavelength (Å) 0.97916 0.97943 0.9799 
Observed reflections 123758 124264 206411 
Unique reflections 8834 8879 36270 
Completeness (%) 99.9 99.9 98.7 
Overall (I/σI) 12.8 12.5 14.8 
Rsyma (%) 10.3 10 7.1 
Refinement and quality    
 Resolution range (Å)  I>σ(I)                               20 – 1.9 
 Rworkb (no. of reflections)      0.215 (36270) 
 Rfreec (no. of reflections)      0.269 (1722) 
 RMSD bond lengths (Å)   0.01 
 RMSD bond angles(deg)   1.7 










Water molecules(342 atoms) 
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Ramachandran plot    
Most favored regions (%)   87 
Additional allowed regions (%)   12 
Generously allowed regions (%)   1 
 Disallowed regions (%)   0 
 
Final overall figure of merit (phasing) = 0.70. 
aRsym = ƩǀIi-<I>ǀ /ƩǀIiǀ where Ii is the intensity of the ith measurement, and <I> is the 
mean intensity for that reflection. 
bRwork = ƩǀFobs _ Fcalcǀ/ƩǀFobsǀ where Fcalc and Fobs are the calculated and observed 
structure factor amplitudes, respectively. 
cRfree = as for Rwork, but for 5.0% of the total reflections chosen at random and omitted 
from refinement. 







 The GrlR model consists of residues from Met1 to Val111, with seven additional 
residues at the N-terminus (Gly-6, Leu-5, Val-4, Pro-3, Arg-2, Gly-1, and Ser0) resulting 
from the linker sequence of the (His) 6 affinity tag. C-terminal residues Asn112 to 
Lys121 were not modeled as no interpretable electron density was present. There are two 
molecules in the asymmetric unit (Fig. 2.9) and they are related by a 2-fold non-
crystallographic symmetry axis approximately parallel to the crystallographic a-axis. 
Interestingly, these two molecules are packed in a perpendicular fashion to each other, 
resulting in maximum interaction.  
 
Figure 2.9. Ribbon diagram of GrlR dimer. Monomer A is shown in red, monomer B in 
green. The dimeric interface residues, surface-exposed residues (EDED motif), and the 
ligand from both monomers are shown in ball and stick representation. This figure was 




 The GrlR molecule mainly consists of a single domain from residues Asp5 to 
Ile107 that form a β-barrel. Residues Tyr59 to Asp70 form an extended loop that plugs 
one side of the cylindrical β-barrel structure. The β-barrel consists of eight anti-parallel β-
strands running from one side of the molecule to the other. On one side of the β-barrel, 
there are four long loops, including a plug-like structure, whereas on the other side, four 
tight β-turns are connecting the adjacent β-strands. Both ends of the β-barrel were closed 
off by the N-terminus (Met1 to Lys4) and the plug-like loop residues Tyr59 to Asp70. 
The tip of the ten residue–long plug-like loop, which is highly hydrophobic, may close or 
open the cavity, primarily by hydrophobic interactions. The β-barrel cavity is highly 
hydrophobic in nature with side chains from seven Tyr, six Ile, seven Leu, four Val, and 
two Phe residues lining the inner cavity surface (Fig. 2.10). The approximate dimensions 
of the β-barrel are 35.2 Å in height and 18.5 Å in diameter. 
 
Figure 2.10. Stereo View of the β-Barrel and the Bound ligand. Stereo view of the Ca 
trace of GrlR β-barrel shown in green, viewed from the top. The hydrophobic side chains 
of the residues from the pore region are shown in thick lines. The ball-and-stick 
representation of the Triton-X100 molecule at the center of the pore is shown. This figure 
was prepared by using Molscript and Raster3D (Kraulis, 1991; Merrit and Bacon, 1997).  
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 GrlR shares 93% to 100% identity between different A/E causing E. coli strains 
and EHEC (strain EDL933) and over 85% sequence identity (CLUSTAL W (Thompson 
et al., 1994) with that of C. rodentium. There is no significant overall sequence identity 
with any other protein in the National Center for Biotechnology Information (NCBI) 
database. A search for topologically similar proteins within the Protein Data Bank (PDB)  
was performed with the program DALI (Holm and Sander, 1998). The highest structural 
homology is observed between GrlR and the electron transport domain of 
quinohemoprotein amine dehydrogenase (PDB code 1jju, with 18% sequence identity, z-
score 9.2 and 2.5 Å RMSD [root mean square deviation] for 90 Cα atoms). This is 
followed by a lipid-binding TTSS secretin pilotin protein, MxiM (PDB code 1y9t, with 
16% sequence identity, z-score 4.90 and 2.7 Å RMSD for 77 Cα atoms), which has a 
cracked barrel structure (Lario et al., 2005).  
 
 During structure refinement, we noticed a small molecule composed of 12 atoms 
in the hydrophobic cavity of GrlR, which, subsequently, was identified to be the fragment 
of Triton-X100. It is worth mentioning here that the bacterial lysis buffer used for GrlR 
purification contained 1% (v/v) of Triton-X100. The detergent may have bound tightly to 
the hydrophobic cavity of GrlR during this stage, and had co-crystallized with GrlR. The 
bound detergent is situated at the center of the cavity and is parallel to its axis (Fig. 2.8). 
The interaction of the detergent with hydrophobic residues of the cavity may play a 
crucial role in increasing the solubility of GrlR (Fig. 2.10). The ligand molecule is well 
defined in the electron density map. Fig. 2.11 shows the simulated annealing Fo-Fc omit 
map. The superimposed GrlR on lipid-bound MxiM (Lario et al., 2005) indicated that the 
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probability of having a lipid molecule in the hydrophobic pore of GrlR is not ruled out. 
Based on structural homology, the bound ligand, and the hydrophobic nature of the cavity 
of GrlR, we suggest that the cavity may recognize a specific small hydrophobic ligand 
and interact with the side chains of the cavity residues. The exact roles of this cavity and 
the plug-like loop in the function of GrlR are not yet established. 
 
Figure 2.11. Stereo View of the β-Barrel and the bound ligand. Simulated annealing Fo-
Fc omit map in the pore region of GrlR. The bound triton molecule and all atoms within 2 
Å of the triton molecule were omitted prior to refinement. The map was contoured at a 
level of 3σ. This figure was prepared using PyMOL (DeLano, 2002). 
 
2.3.3. Dimers of GrlR 
 GrlR exists as a homodimer in solution, with an apparent molecular weight of 29 
kDa, as determined by gel filtration and dynamic light scattering. The analytical ultra 
centrifugation experiments also revealed the dimeric nature of GrlR. These results were 
consistent with a dimeric arrangement observed in the crystal structure, with the dimer 
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having approximate dimensions of 46.5x 32.6 x35.2 Å. The strong hydrophobic cluster at 
the dimeric interface is maintained by the side chains from residues Ile7, Ile23, Ile25, 
Val39, and Ile107 from both monomers of the dimer. In addition, six hydrogen bonding 
contacts (<3.2Å) mainly from Gln41, Glu108, His55, Pro109, and Val 111 of both 
monomers, as well as numerous hydrophobic interactions are maintaining the dimer 
architecture. Fig. 2.14 shows the electrostatic surface representation of the dimeric GrlR 
(GRASP (Nicholls et al., 1991). The observation of a dimeric GrlR for the wild-type as 








Figure 2.13. Sedimentation-velocity data for GrlR. 
 
Figure 2.14. The Electrostatic Surface Potential of GrlR Dimer. The surface-exposed 
(EDED) residues are labeled. It shows a strong negatively charged (red) patch from both 
EDED motifs of the monomers. The dotted line indicates the dimer interface. Bluen 






 GrlR was shown to associate with itself and with GrlA to mediate the regulatory 
network (Barba et al., 2005; Creasey et al., 2003) in ler regulation. GrlA is homologous 
to CaiF, a known DNA binding protein (Buchet et al., 1999), and its sequence analysis 
identified a helix-turn-helix DNA recognition motif at the N-terminus (Barba et al., 
2005). The C-terminal region of GrlA is rich in basic residues (nine arginines and seven 
lysines), suggesting that it may have a role in the interaction with the acidic GrlR. A loop 
region in the crystal structure of GrlR, residues Glu46 to Asp49 (46EDED49), is highly 
exposed on the surface and is less well defined in electron density. It is worth noting here 
that GrlA and GrlR have extremely opposite charges. The calculated isoelectric points 
(pI) of GrlR and GrlA are 4.83 and 9.71, respectively. Taking together all of these facts, 
we now hypothesize that the negatively charged cluster (the EDED [Glu-Asp-Glu-Asp] 
motif) is involved in the GrlR–GrlA interaction and thus may play an important role for 
repressing the ability of EHEC to perform TTSS-mediated protein secretion. 
 
 2.3.4. EDED Motif Is Essential for the Recognition of GrlA  
 
 To test the above hypothesis, the EDED residues were mutated and interactions of 
different GrlR mutants with glutathione-S-transferase (GST)–GrlA were tested by pull-
down assays followed by SDS-PAGE analyses. We found that GrlA was not stable on its 
own, but the GrlA fused with GST was sufficiently stable for pull-down experiments with 
both wild-type and mutant GrlR to verify the binding between these two proteins. We 
have also confirmed that wild-type GrlR binds to GST-GrlA (Fig. 2.15), whereas no 
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binding was observed with GST alone. All of the four single mutants (E46A, D47A, 
E48A, and D49A) and the double mutant (E46A-D47A) of GrlR showed similar binding 
to GrlA in pull-down assays. We expected a similar profile for the other double mutant 
and hence did not generate E48AD49A double mutant. However, the triple mutant 
(E46A-D47A-E48A) showed a significant drop in binding to GrlA. The EDED tetra 
mutant, with all of the four residues mutated to alanine, did not bind to GrlA and no 
protein band corresponding to GrlR was detected in the pull-down assay (Fig. 2.15). 
Bands corresponding to GST-fused GrlA and GrlR were analyzed with peptide mass 
finger printing and their identities were confirmed. The amount of native and mutant 
GrlR protein used in the pull-down assay is shown in Fig.2.16. To verify the integrity of 
secondary structures in the mutants, circular dichroism spectra were measured for wild-
type GrlR as well as for all mutants (Fig. 2.17). In all cases, the circular dichroism spectra 
showed the existence of similar β-sheet secondary structures, which is consistent with the 
crystal structure. These results indicated that the surface-exposed EDED motif is a key 




Figure 2.15. In-vitro pull-down Assay. SDS-PAGE gel showing the in-vitro pull-down 
assay to demonstrate the binding of wild-type GrlR and EDED mutants to GrlA. Lane 1-
molecular weight marker (MW); lane 2-GST; lane 3-E46A-D47A-E48AD49A; lane 4-
E46A-D47A-E48A; lane 5-wild type GrlR; lane 6-E46A-D47A; lane 7-E48A; lane 8-
D47A. The bands corresponding to GST-GrlA and GrlR were further identified by 
peptide mass finger printing. The staining was done using coomassie brilliant blue. 
 
 
Figure 2.16. In-vitro pull-down Assay.  SDS-PAGE gel showing the amount of native 
and mutant GrlR protein used for the in-vitro pull-down assay. Lane1 -molecular weight 
marker; lane2 -E46A-D47A-E48A-D49A; lane3 -wild-type GrlR; lane4 -E46A-





Figure 2.17. Circular dichroism profile for GrlR native and mutants. Red colour- wild 
type GrlR, Dark Blue-E47A, Green-E46A-D47A, Light blue- E46A-D47AE48A. 
 
 
2.3.5. Regulatory Function of GrlR is Mediated by EDED Motif  
 In order to elucidate the role of the wild-type and mutants of GrlR in the 
repression of TTSS, a protein secretion assay was carried out in EHEC. Bacteria 
containing different plasmids were grown in Dulbecco’s Modified Eagle’s Medium 
(DMEM), and total secreted extracellular proteins were recovered from the medium and 
compared by SDS-PAGE. We used EspB, which is a major secreted protein of EHEC, as 
a representative marker and compared the secretion of EspB in wild-type and mutant 
GrlR (Fig. 2.18, upper panel). Wild-type GrlR repressed the secretion of EspB. Single 
(E46A, D47A, E48A, D49A) and double mutants (E46A-D47A) showed similar reduced 
secretion of this protein, whereas the triple mutant (E46A-D47A-E48A) significantly 
reduced GrlR repression and correspondingly the secretion of EspB was increased. 
However, the tetra mutant (E46A-D47A-E48A-D49A) totally abolished the repression 
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effect of GrlR and the secretion of EspB was restored to a level similar to that of the 
control. We have also verified the expression level of all of the GrlR mutants (Fig. 2.18, 
lower panel). These results are consistent with our previous pulldown assays (Fig. 2.15), 
which showed that GrlR and GrlA binding was affected in the triple and tetra mutants. 
Our experiment demonstrated the importance of the EDED motif for carrying out the 
regulatory function of TTSS in EHEC. The EDED motif is required for repression of 
PLEE1 in vivo. A global regulator of TTSS, Ler, which is encoded by the first gene of 
LEE1, positively regulates several secreted proteins, including EspB (Mellies et al., 
1999). It has been shown that GrlR overexpression suppresses the production of Ler 
(Deng et al., 2004; Barba et al., 2005). From our experiments, we have now shown that 
overexpression of wildtype GrlR, but not mutated GrlR, affects the secretion of EspB. 
 
Figure 2.18. General Secretion Profile of EHEC EDL933 Harboring pSA10-grlR and 
Expressing Wild-Type and Mutants of GrlR. Secreted proteins were concentrated from 
supernatants of bacterial culture grown in DMEM and resolved in 12% SDS-PAGE and 
stained with coomassie brilliant blue (upper panel). Western blot of EHEC total cell 
protein against 6His antibody (lower panel). Lane1 – EDL933/pSA10, Lane2 – 
EDL933/pSA10grlR,  Lane3 – EDL933/pSA10grlRE46A, 
Lane4 – EDL933/pSA10grlRD47A, Lane5– EDL933/pSA10grlRE48A, 
Lane6– EDL933/pSA10grlRD49A, Lane7 – EDL933/pSA10grlRE46AD47A,  
Lane8– EDL933/pSA10grlRE46AD47AE48A,  





 The regulatory network that controls the expression of the virulence genes of AE 
pathogens is complex. Much of this complexity is emerged at controlling the activity of 
the PLEE1 and ler expression. We, as well as other groups, demonstrated that Ler is a 
master regulator, turning on and off a large number of virulence genes, including espB 
(Mellies et al., 1999, Li et al., 2004, Iyoda and Watanabe, 2004). The punctually 
temporal regulation of Ler and maintaining its accurate levels of activity are essential for 
successful invasion into the host (Barba et al., 2005; Creasey et al., 2003). The GrlR-
GrlA complex plays a key role in controlling Ler expression (Barba et al., 2005; Deng et 
al., 2004). Iyoda et al (2006) reported recently that the GrlR–GrlA complex also controls 
the expression of FlhDC, the flagella master regulator. Thus, the GrlR–GrlA complex 
plays an important role in controlling the expression of two key master regulators, Ler 
and FlhDC. Our structural study of GrlR identified the surface-exposed EDED motif and 
the importance of these residues was further investigated (Jobichen et al., 2007). Our in 
vivo and in vitro functional studies of wild-type and mutant GrlR showed that the EDED 
motif is crucial for the recognition of GrlA by GrlR and for the GrlR regulatory activity. 




 Based on the properties of GrlR and GrlA proteins, the location of the EDED 
motif in the dimeric GrlR and the dimeric nature of most of the helix-turn-helix–
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containing DNA binding proteins, we propose that the GrlA may also exist as a 
homodimer, and that dimers of GrlR and GrlA in combination are involved in the 
regulatory mechanism. Our study provides a novel structural basis for an understanding 
of the regulatory mechanism of the GrlA–GrlR complex and thus provides new insight 




























Structural basis for the Lipid Recognition of GrlR, a Locus of 





















Enterohemorrhagic E. coli (EHEC) and enteropathogenic E. coli (EPEC) belong to the 
family of attaching and effacing (A/E) pathogens. During infection, these pathogens use 
the type III secretion systems (T3SS) to inject effector proteins into the host cells.  The 
components and related proteins of T3SS are clustered in the LEE. GrlR is a regulatory 
protein which plays a major role in the regulation of LEE proteins through its interaction 
with GrlA, another key regulator. The crystal structure of GrlR is described in detail in 
chapter 2 (Jobichen et al., 2007).  
Structural analysis of GrlR revealed the presence of a hydrophobic cavity in its β-barrel 
architecture, a feature most commonly observed in lipocalins. Lipocalins are a 
widespread family of proteins identified in eukaryotes and in gram-negative bacteria 
(Bishop et al., 1995; Bishop, 2000). They are the carriers of lipophilic molecules but their 
functions are often elusive and very diverse (Akerstom et al., 2000).  The amino acid 
sequences of lipocalins are poorly conserved except the most general signature sequence 
GXW at the N-terminus (Flower et al., 2000; Flower, 2000). However, GrlR contains a 
GXY motif at the N-terminus instead of the highly conserved GXW motif. Lipocalins 
play important role in cryptic coloration, enzymatic synthesis and pheromone transport; 
they have also been implicated in immune response regulation and modulation of cell 
homeostasis (Flower, 1995). The lipocalin fold comprises an 8 stranded β-barrel followed 
by an α-helix at the C-terminus (Flower et al., 1993; Flower, 2000). Blc is the first 
bacterial lipocalin structurally characterized from E. coli (Campanacci et al., 2004). The 
most prominent structural feature of the lipocalin fold is the presence of a large cup-
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shaped cavity within the β-barrel and a loop scaffold at its entrance. The selectivity of 
lipocalin is determined by the amino acid composition of the cavity and loop scaffold, as 
well as its overall size and conformation (Flower, 1995). GrlR shares a very high 
structural similarity with other well-characterized lipocalins, which prompted us to 
investigate the lipid binding property of GrlR.  
 As the continuation of our efforts to understand the structure and function of 
GrlR, here we report the identification and characterization of the lipid binding property 
of GrlR. Based on structural analysis combined with literature search, we hypothesize 
that lysophosphatidic acid (LPA) is likely to be the candidate substrate that interact with 
the hydrophobic cavity of GrlR. To verify this hypothesis, we have determined the crystal 
structure of the LPA-GrlR complex and performed isothermal calorimetry experiments 
with LPA and GrlR.  Further we have studied and compared the lipid binding property of 
GrlR with its lipocalin structural homologs. Subsequently, we have identified the 
physiologically relevant lipid species for GrlR using a mass spectrometry approach. Our 
studies demonstrate the lipid binding property of GrlR and identify the physiologically 
relevant family of lipid species that are recognized by GrlR for its hitherto unknown 
second function.  
3.2. Materials and methods 
3.2.1. Protein purification and Crystallization 
Plasmid DNA was transformed into E. coli BL21 and the cells were grown in LB 
medium at 37ºC to 0.6 AU at OD600. One liter of culture was induced with 100 µM IPTG 
and continued to grow at 20ºC overnight. Cells were then harvested by centrifugation and 
resuspended in 40 ml of lysis buffer (50 mM Tris-HCl, pH 7.5, 0.4 M NaCl, 1 mM 
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EDTA, 10 mM βmercaptoethanol and one tablet of CompleteTM protease inhibitors 
(Roche Diagnostics). The protein was purified in three steps, using DEAE-Sepharose 
(Amersham Pharmacia), NI-NTA (Qiagen) and Gel Filtration (Superdex75) columns, 
respectively. The His-fusion tag was not cleaved. Drops containing 1 µl GrlR lipid 
complex (4 mg/ml) and 1 µl reservoir solution were equilibrated by hanging drop vapor 
diffusion at 21ºC. The best crystals were grown from 25% ethylene glycol, 4% tert-
butanol and 4% trifluoroethanol (same condition as the apoprotein) with the protein in 20 
mM Tris-HCl, pH 7.5, 200 mM NaCl. Crystals measuring ~0.2 mm in length grew over 
the course of 3 days, belonged to space group P212121 with a=43.73, b=66.02, c=83.46Å 
and contained two molecules in the asymmetric unit. The Matthews (Matthews, 1968) 
coefficient is 2.2 Å3/Da, giving a solvent content of 45%. The X-ray data collection and 
refinement statistics were given in Table 3.2. 
3.2.2. Data collection, structure solution and refinement  
 Crystals were cryo-protected in the reservoir solution supplemented with 40% 
ethylene glycol and flash cooled at 100oK. X-ray diffraction data were collected at beam 
line X29A, Brookhaven National Laboratory using a Quantum-4 CCD detector (ADSC). 
A total of 180 images at one degree oscillation were collected at 1.1Å wavelength.  All 
the data sets were processed with HKL2000 (Otwinowski and Minor, 1997). The 
structure was determined using co-crystallized protein crystals by molecular replacement 
method using Phaser (McCoy, 2007) program in the CCP4 crystallographic suite (CCP4, 
1994; Potterton et al., 2003). Native GrlR model was used to obtain the phasing and the 
structure was further modeled with CNS (Brunger et al., 1998). The remaining residues 
of the molecules were added after several cycles of manual model building using O 
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(Jones et al., 1991) and followed by refinement using CNS (Brunger et al., 1998).  
Finally, 264 well-defined water molecules were added, and refinement was continued 
until the R-value converged to 0.231 (Rfree = 0.278) for reflections I>σ(I) to 2.5Å 
resolution. The model had good stereochemistry, with all residues falling within the 
allowed regions of the Ramachandran plot (Table 3.2) analyzed by PROCHECK 
(Laskowski et al., 1993).  
Coordinates of GrlR lipid complex have been deposited in the Protein Data Bank under 
accession code 3E3C 
 
3.2.3. Isothermal titration calorimetry 
 
 ITC was performed using a VP ITC (MicroCal). GrlR protein was purified using 
affinity chromatography and gel filtration in 20 mM Tris-HCl buffer at pH 7.5. The 
purified protein sample was analyzed using mass spectrometry to confirm that no lipid 
species are bound to it. Bovine β-lactoglobulin (purchased from Sigma Aldrich) was used 
without further purification, and dialyzed into 20mM Tris-HCl buffer. All lipid samples 
were at pH 7.5 in 20 mM Tris-HCl. Titrations were performed by injecting consecutive 5-
10 µl aliquots of lipid solution (0.9–1.0 mM) into the ITC cell containing GrlR or β-
lactoglobulin (0.015 mM) at pH 7.5 in 20 mM Tris-HCl. The ITC data were corrected for 
the heat of dilution of the titrant by subtracting mixing enthalpies for injections of lipid 
solution into protein-free buffer. Two to four independent titration experiments were 
performed at 20oC to determine the binding constant of lipid to GrlR. The ITC data 
analysis was performed using software developed in our laboratory implemented in 
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Origin 7.0 (OriginLab). Because both proteins GrlR and β-lactoglobulin are 
homodimeric, the protein dimer was employed as the functional unit. A general model 
based on the overall binding constants for two ligand binding sites, or the model with two 
identical cooperative ligand binding sites was used in the data analysis. 
3.2.4. Lipid Extraction 
The PBS washed Ni-NTA precipitates extracted with 600 µl of ice cold chloroform: 
methanol (1:2). The tubes were vortexed for 1 min and then transferred to a roller shaker 
in cold room for 1 h. Following incubation, 300 µl of ice cold chloroform was added and 
the tube was vortexed for 30s. The phase was broken with the addition of 200 µl of ice 
cold water. The lipids were extracted by vortexing for 2 min. The phases were separated 
by centrifugation at 9000 rpm for 5 min. The lower organic phase was transferred to a 
fresh tube. To the remaining aqueous phase, 300 µl of chloroform was added. The phases 
were vortexed for 2 min and then separated by centrifugation. The lower re- extracted 
organic phase was pooled with the initial organic phase. The lipids were dried in a speed 
vacuum. The dried lipids were stored at -80oC till further analysis. Before analysis the 
lipids were resuspended in 150 µl of chloroform: methanol (1:1). 
3.2.5. Mass Spectrometry Analysis 
For general profiling, the lipids were initially separated on an XTerra C18 reverse phase 
column (1 mm x 150 mm) (Waters Corporation) before entering into the mass 
spectrometer. Typically, 5 µl of sample was injected for analysis. The inlet system 
consisted of a CapLC auto sampler, and a CapLC pump. Chloroform-methanol 1:1 (v/v) 
with 15 mM piperidine was used as the mobile phase for isocratic elution at a flow rate of 
10 µl/min. The column elutes were measured using electrospray ionization mass 
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spectrometry (ESI-MS) through a Micromass Q-Tof micro mass spectrometer (Waters 
Corporation) operated in the negative ion mode. The capillary voltage and sample cone 
voltage were maintained at 3.0 kV and 50 V, respectively. The source temperature was 
80°C and the nanoflow gas pressure was maintained at 0.7 bar. The mass spectrum was 
acquired from m/z 00 to 1200 in the negative ion mode with an acquisition time of 25 
min; the scan duration was 1.2 s.  Individual molecular species were identified using 
tandem mass spectrometry and the collision energy used ranged from 25 to 80 eV.   
Quantification of individual lipid molecular species was performed using multiple 
reaction monitoring (MRM) with an Applied Biosystems 4000 Q-Trap mass 
spectrometer. Samples were directly introduced into the mass spectrometry using an 
Agilent autosampler. Each individual ion dissociation pathway for the lipid species was 
optimized with regard to collision energy to minimize variations in relative ion 
abundance due to differences in rates of dissociation. An optimized 15 µl of samples was 
injected per run per set with chloroform-methanol 1:1 (v/v) as the mobile phase at the 
flow rate of 200 µl/min. The run was carried out for 2 min.  
 
3.3. Results  
3.3.1. GrlR has a lipocalin like fold 
A search on the coordinates of GrlR (PDB code 2ovs) for structurally similar proteins 
was performed using the program DALI (Holm and Sander, 1998). This search identified 
several lipocalins with significant structural similarity to the β-barrel architecture of 
GrlR. While having poor or no sequence homology, lipocalins are structurally very 
similar to each other.  The BLAST (Altschul et al., 1997) (NCBI) search on the GrlR 
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sequence revealed no significant sequence similarities with other lipocalins that are 
structurally similar to GrlR (Fig. 3.1). Lipocalins posses a structurally conserved C-
terminal helix at one side of the eight-stranded β-barrel. In GrlR the C-terminal last 11 
residues are not clearly visible in the electron density map and this region is presumably 
disordered. However based on the sequence analysis and modeling this region is likely to 
form a two-turn helix. We speculate that the C terminal region of GrlR is a flexible 
region with a minimum of two-turn α-helix. The highest structural similarity is observed 
between GrlR and the lipid-binding domain of β-lactoglobulin, a core lipocalin, yielding 
an rmsd of 2.8Å for 92 Cα atoms (PDB code 1beb; 15% sequence identity). This is 
followed by the retinol binding protein (PDB code 1aqb; rmsd=3.3Å for 98 Cα atoms; 
12.6% sequence identity). In addition, 23 lipocalin-like structures or lipid binding 
proteins revealed significant structural homology with GrlR (Table 3.1). It is worth 
mentioning that a T3SS secretin pilot protein from Shigella flexneri bound with lipids 
also shows high structural similarity with GrlR (Lario et al., 2005) (rmsd of 2.8Å for 77 
Cα atoms; 16% sequence identity; PDB code 1y9t).  All the lipocalins have a 
hydrophobic cavity through which they bind with lipid molecules. For instance, the folds 
of lipocalins Blc, the first structurally known bacterial lipocalin (Campanacci et al., 
2004) and Mxim (Lario et al., 2005) are identical to each other and very similar to GrlR. 
These observations suggest that the β-barrel architecture is an evolutionarily conserved 
structural feature for the lipocalins or lipid binding proteins, while at the same time the 
amino acid sequence of these proteins has diverged to acquire different lipid specificities 
for their functional roles (Fig. 3.2). Based on the size, hydrophobic nature of the β-barrel 
cavity and structural similarity with other lipocalins, three lipid molecules were identified 
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to interact with GrlR. The lipid molecules which are likely to interact with GrlR are (1) 1, 
2-dioctanoyl-sn-glycero-3-phosphate, (2) 1-hexanoyl-2-hydroxy-sn-glycero-3-phosphate 
(HHGP) and (3) 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine. However 
due to the limited solubility of these lipids only HHGP was suitable to conduct the ITC 
and structural studies.  In order to demonstrate the lipid binding property of GrlR is 
similar to β-lactoglobulin (a well-known lipocalin structurally homologous to GrlR) we 
have studied the binding of HHGP with β-lactoglobulin.   
 
 
Table 3.1. Structural homologue of GrlR with lipid binding proteins (based on DALI 
search)  
 
No  STRID2 Z RMSD LALI LSEQ2 PROTEIN 
1 1beb 6.2 2.8 92 156 β-lactoglobulin 
2 1aqb 6.2 3.3 98 175 Retinol binding protein 
3 1obp 5.9 2.7 87 158 Odorant binding protein 
4 1epa 5.4 3.2 85 151 Retinoic acid binding protein 
5 1qwd 5.0 2.8 86 167 Outer membrane lipoprotein blc 
6 1y9t 4.9 2.7 77 110 Lipoprotein mxim 
7 1bbp 4.9 3.0 91 173 Bilin binding protein 
8 1y9l 4.8 2.8 78 110 Mxim 
9 2fgs 4.2 3.1 82 169 Putative periplasmic protein 
10 2byo 4.2 3.6 66 183 Lipoprotein expression system vector 
11 1qft 4.0 3.1 87 175 Female specific histamine binding 
12 2in5 3.5 2.7 60 190 Hypothetical lipoprotein ymcc 
13 1oee 3.4 3.1 78 185 Stress protein hypothetical protein yoda 
14 1mix 3.1 4.0 61 206 Structural protein talin fragment 
15 1izn 3.1 3.2 69 275 Protein binding capz alpha-1 subunit  
16 1jzu 3.0 3.2 75 157 Lipocalinq83 mutant 
17 1hmt 3.0 3.5 63 131 Fattyacid binding protein 
18 1lsh 2.8 6.5 59 174 Lipovitellin  
19 1osp 2.7 4.3 73 251 Immunoglobulin lipoprotein complex 
20 1djx 2.7 4.0 74 561 Lipid degradation phosphoinositide-specific 
21 1t8v 2.2 3.5 61 131 Fatty acid binding protein 
22 1v88 2.1 2.8 55 130 Oxysterol binding protein 











Figure 3.2.  Sequence alignment of GrlR with major lipocalins. The alignment was 
performed using ClustalW (Larkin et. al., 2007) and the Figure was prepared using 





Figure 3.1. Superposition of GrlR with major lipocalins. GrlR - green, Retinol binding 
protein (pdb code 1JYD) - blue, Major Urinary protein (pdb code 1MUP) - violet, Outer 
membrane lipoprotein blc (pdb code 1QWD) - yellow, Outer membrane enzyme pagp 
(pdb code 1THQ)-brown. This Figure was prepared using Pymol software (DeLano, 
2002) 
 
3.3.2. Isothermal Titration Calorimetric studies  
 Initially, ITC experiments were conducted for the three identified lipid molecules 
to determine the binding affinities. However, 1, 2-dioctanoyl-sn-glycero-3-phosphaate 
and l-palmitoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine were not completely 
soluble in Tris-HCl buffer, pH 7.5- 8.5, at 20oC, and we were able obtain interpretable 
data only for 1-hexanoyl-2-hydroxy-sn-glycero-3-phosphate (HHGP). The results 
indicated that HHGP exhibits a micromolar binding affinity for GrlR and β-lactoglobulin, 
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a closest lipocalin structural homologue of GrlR (Fig. 3.2). Titrations of GrlR and β-
lactoglobulin with HHGP showed negative power deflections indicating an apparent 
exothermic reaction during the binding. GrlR is a dimer in solution as well as in crystal 
(Jobichen et al., 2007), and two ligand molecules were found to bind to one dimer of 
GrlR.  Likewise, β-lactoglobulin is a homodimeric protein. Therefore, the dimer was 
considered as the functional unit with two binding sites, and the concentration of protein 
was employed in a dimer basis (0.015 mM). The calorimetric titrations observed with 
HHGP binding to both proteins do not correspond to a system with identical binding 
sites, and nonidentical and/or cooperative binding sites must be assumed. This is further 
evidence for considering the dimer as the functional entity. Because the protein is a 
homodimer, with two identical binding sites in the absence of ligand, the two binding 
sites must exhibit (positive or negative) cooperativity. 
Experimental data were analyzed employing a general model based on the overall 
association constants, βi, and binding enthalpies, ∆Hi, associated with the formation of 
complex MLi (Wyman and Gill, 1990), from which information on the type of binding 
sites may be directly inferred. 
 The non-linear regression analysis indicated that two ligands are binding to a 
GrlR dimer with β1 = (8.4 ± 0.9)·105 M-1, ∆H1 = -0.1 ± 0.4 kcal/mol, β2 = (8.4 ± 0.7)·1011 
M-1, ∆H2 = -7.1 ± 0.4 kcal/mol, n = 1.08 ± 0.06. The parameter n is not the stoichiometry, 
already accounted for in the model, but the fraction of active protein. The cooperativity 
parameter 4β2/β12 is equal to 4.7, which indicates that the binding sites exhibit positive 
cooperativity. Further, the experimental data were analyzed employing a positive 
cooperativity model with two identical binding sites, using explicitly the microscopic 
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association constant, k, and binding enthalpy, ∆H, for each binding site, and the 
cooperativity constant, κ, and the cooperativity enthalpy, ∆h. The non-linear regression 
analysis indicated that two ligands are binding to a GrlR dimer with k = (4.2 ± 0.4)·105 
M-1, ∆H = -0.1 ± 0.4 kcal/mol, κ = 4.7 ± 0.3, ∆h = -6.8 ± 0.4 kcal/mol, n = 1.08 ± 0.06. 
These values are identical to the ones calculated directly from the parameters obtained 
with the general model based on the overall parameters using the appropriate linking 
equations between the two models. 































































Figure 3.3. ITC data for the titration of (A) 0.9 mM hexanoyl-2-hydroxy-sn-glycero-3-
phosphate (HHGP) into 0.015 mM GrlR, and (B) 1.0 mM hexanoyl-2-hydroxy-sn-
glycero-3-phosphate (HHGP) into 0.015 mM β-lactoglobulin. The upper panels contain 
the baseline-corrected raw data, and the lower panels show the peak-integrated, 
concentration normalized heats of reaction versus the molar ratio. The solid line in the 
lower panels represents the best fit of the data using the general model using the overall 
binding constants for two binding sites, or the model with two identical binding sites with 




 The non-linear regression analysis also indicated that two ligands are binding to a 
β-lactoglobulin dimer with β1 = (1.4 ± 0.3)·106 M-1, ∆H1 = -2.2 ± 0.4 kcal/mol, β2 = (1.8 
± 0.4)·1010 M-1, ∆H2 = -13.9 ± 0.4 kcal/mol, n = 0.98 ± 0.08. The cooperativity parameter 
4β2/β12 is equal to 0.038, which indicates that the binding sites are non-identical or they 
exhibit negative cooperativity. β-lactoglobulin is homodimeric, and hence the 
experimental data were analyzed employing a negative cooperativity model with two 
identical binding sites using explicitly the microscopic association constant, k, and 
binding enthalpy, ∆H, for each binding site, and the cooperativity constant, κ, and the 
cooperativity enthalpy, ∆h. The non-linear regression analysis indicated that two ligands 
are binding to a β-lactoglobulin dimer with k = (7.2 ± 0.9)·105 M-1, ∆H = -2.2 ± 0.4 
kcal/mol, κ = 0.038 ± 0.05,  ∆h = -9.5 ± 0.4 kcal/mol, n = 0.98 ± 0.08. 
The ITC data suggests that each monomer of GrlR interact with one molecule of 1-
hexanoyl-2-hydroxy-sn-glycero-3-phosphate (HHGP) molecule. We speculate that lipids 
with two longer hydrocarbon tails may engage simultaneously with the dimeric GrlR, 
with one tail for each monomer. The highly hydrophobic nature of longer chain lipids 
prevented us from performing further ITC experiments. 
 
3.3.3. Structure of GrlR Lipid complex 
We attempted to co-crystallize each of the three lipid molecules with GrlR, however, 
diffraction quality crystals were obtained only for the 1-hexanoyl-2-hydroxy-sn-glycero-
3-phosphate (HHGP) with GrlR. In our previous study, the lipid binding cavity of GrlR is 
occupied by a Triton-X100 molecule which was present in the lysis buffer. During the 
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co-crystallization of GrlR with HHGP, we titrated the protein with HHGP using ITC and 
concentrated the resulting complex for setting up the crystallization screens. Moreover, 
we did not use any Triton-X100 during the lysis and purification stage. The structure of 
recombinant GrlR in complex with HHGP was solved by the molecular replacement 
method using a synchrotron data set and refined to a final R-factor of 0.231 (Rfree=0.278) 
at 2.5Å resolution. There are two GrlR-lipid complex molecules in the asymmetric unit 
(Fig. 3.4). The simulated annealing omit map (Fig. 3.5) of the bound HHGP molecules 
shows well defined electron density map.  The model has been refined with good 
stereochemical parameters (Table 3.1). All the residues of GrlR including the N-terminal 
linker were well defined in the electron density map, except for the last ten residues at the 
C-terminus.  
The GrlR molecule in the GrlR-HHGP complex is highly similar to that of our previously 
determined GrlR structure (Jobichen et al., 2007). GrlR is a single domain β-barrel 
protein. The β -barrel consists of eight anti-parallel β-strands running from one side of the 
molecule to the other. The inner cavity region of the lipocalins is found to be highly 
hydrophobic and assumed to be a prerequisite for lipid binding. The diameter of the 
hydrophobic pore of GrlR is comparable to most of the well known lipocalins (Fig. 1B).  
In the GrlR-HHGP complex there are 30 hydrophobic side chains having extensive 
hydrophobic interactions with the bound lipid molecule.  The ends of the β -barrel are 
closed off by the N-terminus (Met1 to Lys4) and plug residues Tyr59 to Asp70.  This 
indicates that transport through the hydrophobic cavity is restricted.  
  Structural comparisons of GrlR with lipocalins revealed an extended loop (L1) 
(the plug region Tyr59 to Asp70 of GrlR) on one side of the β-barrel, which is 
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significantly longer than other loops (Fig. 3.6). This loop may act as a plug to close and 
open the pore. Several highly conserved hydrophobic residues are located at the middle 
of this loop.  The conformation and nature of this extended loop scaffold (plug region) is 
similar in all lipocalins. In retinol binding proteins, this loop is shown to be partially 
responsible for the binding of lipid molecules (Flower et al., 1993). The loop (L3) in 
GrlR, located opposite to the extended loop (plug) has two conserved residues (D17, S18) 
(Fig. 3.6). Similar conserved residues are also observed in PagP (D76 and S77) (Hwang 
et al., 2002) and Mxim (D124 and T125) structures. These two conserved residues have 
been reported to be important for the catalytic acyltransferase activity in PagP (Hwang et 
al., 2002). Moreover, MxiM has been proposed as a soluble acyltransferase that may act 
to lipidate components of the T3SS (Lario et al., 2005).  Similar to the structure of PagP, 
the loops of GrlR are flexible to accommodate the binding of lipid molecules. A small 
change in phi-psi angle at both end of the extended loop (L1) may facilitate the opening 
and closing of the pore, and thus regulate the movement of the lipid molecules through 
the pore. Considering the high structural similarities of GrlR with PagP and Mxim and 














Table3.2. Data collection and refinement statistics 
 
 
Data collection High resolution 
Space group P212121 
Cell dimensions   
a, b, c (Å) 43.73, 66.02, 83.46 
α, β, γ (°) 90, 90, 90 
Resolution (Å) 2.5 
aRsym  10.3 
I / σI 8.2 
Completeness (%) 98.9 
Redundancy 6.7 
Refinement  
Resolution (Å) 20- 2.5 
No. reflections 8751 
bRwork / cRfree 0.231 / 0.278 




 B-factors   
Protein 34.256 
 Ligand/ion 36.48 
 Water 51.869 
R.m.s deviations  
    Bond lengths (Å) 0.01 
    Bond angles (°) 1.7 
Ramachandran Plot  
Most favorable regions (%) 84.2 
Additional allowed regions (%) 13.9 
Generously allowed regions (%) 2.0 
Disallowed regions (%) 0 
         
      
a
 Rsym = |Ii -<I>|/ |Ii| where Ii is the intensity of the ith measurement, and <I> is  the 
mean   intensity for that reflection. 
       
b
 Rwork = | Fobs - Fcalc|/ |Fobs| where Fcalc and Fobs are the calculated and observed 
structure factor amplitudes, respectively. 
      
c





Figure 3.4. Overall structure of GrlR with bound 1-hexanoyl-2-hydroxy-sn-glycero-3-
phosphate (HHGP).  Ribbon diagram of dimer and bound HHGP is shown in stick 






Figure 3.5. Simulated annealing Fo-Fc omit map in the pore region of GrlR. The bound 
hexanoyl-2-hydroxy-sn-glycero-3-phosphate (lipid) molecule and all atoms within 2 A° 
of the lipid molecule were omitted prior to refinement. The map contoured at a level of 




 Figure 3.6.  Loop arrangements in GrlR, different loops are numbered (Loop1 to 
Loop4). See the conserved D17 and S18 residues in the loop 3. This Figure was prepared 
using Pymol (DeLano, 2002). 
 
3.3.4. Mass spectrometry analysis to identify the physiological lipid species bound to 
GrlR 
In order to establish a physiological role of the lipid binding property and to identify the 
relevant lipid species, mass spectrometry experiment was carried out. His tagged GrlR 
was over expressed in bacterial cells and purified using Ni-NTA resins, and was used for 
lipid extraction. Comparison of profiles between uninduced and induced Ni-NTA extracts 
is shown in Fig. 3.7.The extracted lipid was analyzed by Q-TOF mass spectrometry to 
obtain a complete lipid profile of the lipid species that co-purified with GrlR. A 
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representative lipid profile for the GrlR bound species is shown in Fig. 3.8B. The total 
cell lipid extract was taken as controls (Fig. 3.8A). In order to discriminate with non-
specific bindings, a reference protein, ribosomal modifying methyltransferase (PrmB), 
which is not reported to bind to any lipids, was also included in the analysis. His-tagged 
PrmB was over expressed and purified with Ni-NTA. The lipids were extracted from the 
protein in a similar fashion as that of the GrlR protein. The lipid profile generated from 
PrmB is shown in Fig. 3.8C. Comparison between the GrlR and the PrmB lipid profile 
showed drastic differences. Species with the m/z ratio of 688, 714, 716, 719, 742, 745, 
747 and 773 were observed to be significantly higher in the GrlR extracts compared to 
the PrmB extract. These species were observed to be absent in the Ni-NTA lipid extracts 
from the un-induced bacterial cultures. Identification of the species was carried out using 
tandem mass spectrometry. Phosphatidylglycerol and phosphatidylethanolamine species 
with fatty acid chains of 16:0, 16:1 or 18:1 were observe to be bound to the protein (Fig. 






Figure 3.7. Comparison of lipid profiles between uninduced and induced Ni-NTA 
extracts of GrlR (Top Panel).The m/z ratio of the peaks which showed significant 




Figure 3.8. Lipid profile using mass spectrometry. The lipid were extracted from (A) 
GrlR over-expressed cells (B) Ni-NTA extracts from GrlR over-expressed cells and (C) 
Ni-NTA extracts from methyl transferase over-expressed cells. The data is the 





Fig. 3.9. Basic structure of phosphatidylglycerol and phosphatidylethanolamine. R1, R2, 
R3 and R4 indicates the fatty acids 
 
 A multiple reaction monitoring (MRM) based approach was used to quantify 
these lipid species in the extracts. In these experiments, the first quadrupole, Q1, is set to 
pass the precursor lipid ion of interest to the collision cell, Q2, where it underwent 
collision-induced dissociation. The third quadruple, Q3, was set to pass the structure 
specific product ion characteristic of the precursor lipid of interest. MRM is very 
sensitive and is able to quantify the lipid species with less interference from other lipid 
species which could also be of the same m/z. The MRM method was built for the 
identified lipids and the extracts were used for quantification. As expected, the levels of 
the identified lipids were observed to be significantly higher in the GrlR extracts as 
compared to that in the un-induced control and the PrmB extracts (Fig. 3.10). The data 
obtained from Q-Tof analysis was confirmed with the MRM data which also showed 
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phosphatidylglycerol and phosphatidylethanolamine species with fatty acid chains of 
16:0, 16:1 or 18:1 were bound to the protein GrlR. 
 
 
Figure 3.10. MRM based quantification of lipids. The Ni-NTA lipid extracts from the 
uninduced (grey box), GrlR over expressed (open box) and the methyl transferase over 
expressed (black box) cells were passed through MRM based quantification for 
phosphatidylglycerol and phosphatidylethanolamine. The number below the bars 
indicates the fatty acid composition of the respective lipid class. The data is from 3 
replicates and is the representative of 3 different sets of experiments. 
 
Discussion  
 Structural analysis of GrlR showed that its fold is highly similar to lipocalins or 
lipid binding proteins. A Triton-X100 molecule was bound in the hydrophobic cavity of 
the native GrlR. Based on the cavity size and analysis of homologous structures, we 
predicted that lysophosphosphatidic acid (LPA) can bind to the cavity and subsequently 
HHGP a representative member of LPAs was chosen for this study.  We have co-
crystallized the GrlR-HHGP complex and determined its structure. The crystal structure 
of GrlR with bound lipid ligand showed a dimeric arrangement with a lipid molecule 
bound to each monomer of the protein. Furthermore, we have performed isothermal 
calorimetry studies and identified the parameters for the binding of HHGP to GrlR. In 
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addition the binding of HHGP with β-lactoglobulin has been studied and compared with 
GrlR.  
 Although GrlR and β-lactoglobulin bind HHGP, according to the data analysis of 
the ITC experiments the two binding sites in GrlR and β-lactoglobulin dimers show 
positive and negative cooperativity, respectively. The cooperativity interaction parameter 
value of 4.7 for GrlR corresponds to a cooperativity Gibbs energy value ∆g of -0.9 
kcal/mol, whereas the value of 0.038 corresponds to +1.9 cal/mol. The estimated value of 
the Hill coefficient for GrlR and β-lactoglobulin are 1.37 and 0.33, respectively, 
compared to a value of 1 for independent ligand binding. 
 The intrinsic HHGP binding to GrlR and β-lactoglobulin is characterized by a 
similar moderate affinity (k = (4.2 ± 0.4)·105 M-1, kd = 2.4 µM for GrlR; k = (7.2 ± 
0.4)·105 M-1, kd = 1.4 µM for β-lactoglobulin) with a Gibbs energy of binding of -7.5 
kcal/mol and -7.9 kcal/mol, respectively, and it is entropically driven (∆H = -0.1 ± 0.4 
kcal/mol, -T∆S = -7.4 ± 0.4 kcal/mol for GrlR; ∆H = -2.2 ± 0.4 kcal/mol, -T∆S = -5.7 ± 
0.4 kcal/mol for β-lactoglobulin). Therefore, the intrinsic parameters for the binding of 
HHGP to GrlR and β-lactoglobulin are similar: micromolar binding affinity, small 
binding enthalpy, and binding dominated by entropy. This is what would be expected for 
the binding of an apolar molecule: hydrophobic desolvation as the predominating 
phenomenon, resulting in a remarkable entropy gain and a small enthalpic contribution. 
 The binding of physiological lipid species with GrlR is further confirmed using 
mass spectrometric studies that compared the profiles from un-induced and induced 
bacterial culture. We also identified phospatidylglycerol (PG) and 
phosphatidylethanolamine (PE) as the two major lipid species bound to GrlR. It is well 
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known that PE and PG are the major lipid components of bacterial membranes. The inner 
membrane of E. coli contains 70–80% PE and 20–25% PG (Dowhan, 1997). The 
phosphatidylglycerols and phosphatidic acids differ to some extent in terms of their 
chemical entities. Phosphatidic acid with a glycerols group becomes 
phosphatidylglycerol. HHGP which showed micromolar binding affinity in ITC 
experiment has a head group of phosphatidic acid. Previous studies shows that a major 
urinary protein (MUP) of mouse (PDB code 1MUP) (Bocksei et al., 1992; Cavaggioni et 
al., 1990) binds with a number of odorant molecules with varying affinity. A similar 
multiple binding was also reported in odorant binding protein (Monaco and Zanotti, 
1992). Using mass spectrometry experiments we have identified the binding of two 
different lipid species in GrlR. 
 Further our ITC experiments with HHGP and β-lactoglobulin demonstrate that 
HHGP binds to β-lactoglobulin. β-lactoglobulin is a well studied lipocalin and its crystal 
structures have been reported in complex with palmitic acid (PDB code 1b0o (Wu et al., 
1999), 12-bromododecanoic acid (PDB code 1bso (Qin et al., 1998)) and retinol (PDB 
code 1gx8 (Kontopidis et al., 2002)). The structural comparison of the β-lactoglobulin-
lipid complexes compares well with GrlR-HHGP structure. Moreover, the binding of 
HHGP with other known lipocalins like blc (Campanacci et al., 2004) and Mxim (Lario 
et al., 2005) were previously reported. Besides, the co-crystal structure of Mxim with 
HHGP is similar to GrlR: HHGP complex. HHGP showed micro-molar binding affinity 
with both GrlR and Mxim (Lario et al., 2005).  
 Future studies will be directed towards understanding the relationship, if any, 
between the regulatory and lipid binding function of GrlR. We speculate that GrlR might 
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be having multiple functions as a regulatory protein as well as lipid binding/transport 
protein and these functions may be changed according to the physiological condition of 
the bacteria. In this context it is worth mentioning here that the bacterial outer membrane 
enzyme PagP was found to transfer a palmitate chain from a phospholipid to lipid A 
(Hwang et al., 2002). PagP is a close structural homologue of GrlR, suggesting that GrlR 













































Structural Basis for the Secretion of EvpC: A Key Type VI 














  The Type VI secretion system (T6SS) is a recently described mechanism used by 
gram-negative bacteria for the transport of virulence proteins. (Cascales, 2008; Filloux et 
al., 2008).  T6SSs are present in nearly 100 different bacteria (25% of all sequenced 
bacterial species) (Filloux et al., 2008). However the function of this novel secretion 
system remains largely unknown. 
 
 The T6SS cluster in E. tarda is named as Evp (Edwardsiella virulence proteins) 
and it contains 16 different genes (Zheng and Leung, 2007). We have reported the 
sequence of the entire Evp gene cluster and classified the T6SS proteins into three groups 
(1) intracellular apparatus (non-secreted) proteins, (2) secreted proteins and (3) a group of 
proteins which are non-essential for T6SS dependant secretion. Of these, the secreted 
proteins consist of EvpC, EvpP and EvpI (Rao et al., 2004; Zheng and Leung, 2007).  
Further, we showed that EvpC is a key protein required for the secretion of EvpC, EvpP 
and EvpI (Rao et al., 2004; Zheng and Leung, 2007). The secretion of EvpC and EvpI are 
mutually dependent and these two proteins are required for the secretion of EvpP. In E. 
tarda the deletion of evpB or evpC genes reduced the replication rates of the bacteria in 
fish phagocytes (Rao et al., 2004).  Co-immunoprecipitation studies showed that EvpC 
binds with EvpP inside and outside the E. tarda cell. EvpP is a unique T6SS secreted 
protein identified in E. tarda and no homolog of EvpP was reported from other 
organisms, with the exception of a homolog in V. cholerae (MED222_19894, 68% 
identity) with unknown function.  In addition, our previous studies showed that 13 genes 
in the Evp cluster are required for the secretion of EvpC (Zheng and Leung, 2007). EvpC 
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is a key protein with multiple functions: (1) as a component of the secretion apparatus 
and (2) plays a major role in the secretion of other T6SS proteins and its secretion from 
the cell.  
 EvpC has several homologues in pathogenic bacteria such as Y. pestis, A. 
tumefaciens, E. coli, P. aeruginosa, Ralstonia solanacearum, S. enterica. EvpC belongs 
to the family of proteins containing the conserved domain COG3157 Type VI protein 
secretion system component protein, such as Hcp (hemolysin-coregulated protein) (a 
secreted cytotoxin). This conserved domain is implicated in intracellular trafficking, 
secretion, and vesicular transport (Marchler-Bauer et al., 2007; Pukatzki et al., 2006). 
  As a continuation of our efforts to understand the structure and function of T6SS 
proteins, here we report the crystal structure of EvpC from E. tarda refined at 2.8Å 
resolution. EvpC is comprised of a loosely packed β-barrel architecture and an α helix 
located on one side of the β-barrel. There are five surface exposed loops which are in 
contact with other monomers and facilitate the formation of a double hexameric structure 
in crystal packing. Furthermore, structure guided mutagenesis followed by functional 
studies (both in-vitro and in-vivo) have been performed to understand the role of EvpC in 
secretion and interaction with other secreted proteins. Our studies suggest that the 
negatively charged residues located at the N- terminal region of EvpC are implicated in 
the secretion of T6SS proteins. EvpC is a close homolog of Hcp1 from P. aeruginosa 
which is highly conserved in many pathogenic bacteria and involved in lung infections. 
The function and mechanism of EvpC proposed here are likely to be applicable to other 




4.2. Materials and Methods  
4.2.1. Plasmid and strain construction. The evpC gene was PCR amplified from 
Edwarsiella tarda chromosomal DNA and cloned into a derivative of pET vector 
(pETM32) (Novagen) or pGEX-4T1 (Amersham Biosciences) or pSA10 vector for 
secretion assay. The plasmid pGEX-evpP was constructed by amplifying the evpP DNA 
fragments from the Edwarsiella tarda chromosomal DNA and cloned into a derivative of 
pET vector (pETM32) (Novagen) or pGEX-4T1 (Amersham Biosciences).  
4.2.2. Purification and crystallization. Plasmid DNA was transformed into E. coli BL21 
and cells were grown in defined M9 medium (Doublie, 1997) supplemented with 25mg/l 
L-SeMet, at 37ºC until it reached 0.6 AU at OD600. One liter of culture was induced with 
100µM IPTG and continued to grow at 20ºC overnight. Cells were harvested the 
following day by centrifugation and resuspended in 40ml of lyses buffer (50mM Tris-
HCL, pH 7.5, 0.2 M NaCl, 1mM EDTA, 1% (w/v) Triton X-100, 5% (w/v) glycerol, 
2mM DTT and one tablet of CompleteTM protease inhibitors (Roche Diagnostics). The 
protein was purified in three steps, using DEAE-Sepharose (Amersham Pharmacia), NI-
NTA (Qiagen) and Gel Filtration (Superdex200) columns in the same order. The His- tag 
was not cleaved.  
Drops containing 1µl of protein solution (40mg/ml) and 1µl of reservoir solution 
were equilibrated by hanging drop vapor diffusion at 21º C. Crystals grew from a 
reservoir solution contains 0.2M Ammonium sulfate, 0.1M BIS-TRIS pH 6.5 and 25% 
Polyethylene glycol 3350 (Index screen 74) with EvpC in a buffer containing 20mM 
Tris-HCL, pH 7.5, 200mM NaCl, 2mM DTT, and 5 %( w/v) glycerol. Better diffraction 
quality crystals were obtained by the optimization of this condition, mainly by varying 
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the PEG concentration. It is worth mentioning here that only the SeMet protein gave 
diffraction quality crystals. Crystals belonged to the space group P6
 
with two molecules 
in the asymmetric unit. The unit cell parameters were a= 85.45, b=85.45, c=93.07Å and 
the solvent content was 40% (Mathews constant 2.16Å3/Da) (Matthews, 1968) (Table 1). 
4.2.3. Data collection, structure solution and refinement. Crystals were cryoprotected 
with the reservoir solution, which contain ~35% poly ethylene glycol 3350 and flash 
cooled at 100K. Diffraction data were collected using an R-axis IV image plate detector 
mounted on a Rigaku X-ray generator and the collected data were processed with 
HKL2000 (Otwinowski and Minor, 1997). The structure was solved by the Molecular 
replacement method with the program PHASER from the CCP4suite (Mc Coy et al., 
2007). Hcp1 protein was used as the search model (Pdb code 1y12). Model building was 
performed using the program O (Jones et al., 1991) and subsequent refinement was 
performed using Phenix (Afonine et al, 2005). Finally 123 well-defined water molecules 
were added, and refinement was continued until the R-value converged to 0.238 (Rfree = 
0.284) for reflections I>σ(I) to 2.8Å resolution. The model had good stereochemistry, 
with all residues falling within the allowed regions of the Ramachandran plot (Table 1) 
analyzed by PROCHECK (Laskowski et al., 1993) except Glu136 which is well defined 
in the density but located in a loop region.  
4.2.4. In-vitro pull down assay.  The plasmid pGEX-evpP transformed into E. coli strain 
BL21 DE3 and overexpressed under IPTG induction. EvpP with GST tag was 
immobilized in GST sepharose beads (Amersham biosciences) in TRIS buffer (20 mM 
TRIS, 200 mM NaCl, 5% glycerol, 2 mM DTT) and washed with TRIS buffer at different 
salt concentration to remove non-specific proteins bound to the beads. The beads with 
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immobilized EvpP protein were verified for their purity and quantified using SDS PAGE, 
and subsequently used for pull down experiments. Expression and purification of His-
tagged EvpC were performed as described in the previous section. The EvpC protein was 
added onto GST beads bound with pGEX-EvpP and incubated at 4ºC for 15 minutes. The 
beads were washed twice with TRIS buffer at different salt concentration to remove non 
specific binding and resolved on 12% SDS PAGE along with controls. The identity of 
protein bands were confirmed using peptide mass finger printing.  
4.2.5. Analytical Ultra Centrifugation (AUC). The oligomeric state of EvpC and EvpP 
was investigated by monitoring its sedimentation properties in sedimentation velocity 
experiments. Samples used for these experiments were of 0.50 ml in volume and 
consisted of 2.5mg/ml in TRIS buffer (pH 7.0) (Tris-HCl 20 mM, Nacl 200mM, Glycerol 
0.8%, DTT 2mM). The sedimentation velocity profiles were collected by monitoring the 
absorbance at 280 nm as the samples were centrifuged at 40,000 rpm at 200C in a 
Beckman Optima XL-I centrifuge fitted with a six-hole AN-60 rotor and double-sector 
aluminum centerpieces. The scans were analyzed using the program Sedfit (Brown and 
Schuck, 2006). 
4.2.6. MALDI-TOF MS and MS-MS Analysis. The molecular weight of protein bands 
from SDS-PAGE gels was determined by using a Voyager STR MALDI-TOF mass 
spectrometer (Applied Biosystems). For MS/MS analysis, the sample digestion, desalting 
and concentration steps were carried out by using the Montage® In-Gel digestion Kits 
(Millipore Corp.) Protein spots were analyzed using an Applied Biosystems 4700 
Proteomics Analyzer MALDI-TOF/TOF (Applied Biosystems). Data processing and 
interpretation was carried out using the GPS explorer Software (Applied Biosystems) and 
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the database searching was performed using the MASCOT program (Matrix Science 
Ltd).  The NCBI database was used for the combined MS and MS/MS search. 
4.2.7. Secreted protein isolation and assay.  To isolate   the   secreted   proteins of E. 
tarda, overnight cultures of E. tarda strains in LB were diluted at 1:50 into DMEM, 
supplemented with 100mM ampicillin and 0.1mM IPTG, and incubated for 6 h, at 37oC in 
a 5% (v/v) CO2 atmosphere. Bacterial cells were removed from the culture by 
centrifugation (5500 xg, 10 min, 4oC) and the supernatant were collected and passed 
through a 0.22 µm filter and precipitated by 10% TCA as described previously (Li et al., 
2004). The proteins (secreted and cytosolic proteins) were resolved in 12% SDS-PAGE and 
visualized using the Western blot technique.  
 
4.3 Results  
4.3.1. Characterization of EvpC  
The purified SeMet protein was of good quality as indicated by SDS-PAGE (Fig. 4.1), 
gel filtration (Fig. 4.2) and dynamic light scattering experiments (Fig. 4.3). MALDI-TOF 
mass spectrometric experiments indicated that SeMet was successfully incorporated (Fig. 
4.4 top and bottom). Diffraction quality crystals of SeMet EvpC  that were obtained (refer 




Figure 4.1.  SDS-PAGE showing the expression of  EvpC. Lane1 – Low Molecular Weight 
Marker,  Lane2 – Elution1,  Lane3 – Wash 3,  Lane4 – Wash2, Lane 5 – Wash1, Lane 6-
Flowthrough,  Lane7-Gel filtration fraction, Lane8 – Elution2, Lane9– Protein bound to Ni-
NTA beads after elution. 
 
Figure 4.2.  Profile of size-exclusion chromatographic purification of EvpC. The higher 
peak at around 44kDa corresponds to the EvpC protein (Blue colour) and small peak near to 
158kDa corresponds to EvpC hexamer. The X-axis indicates the elution volume in mL and 
the Y-axis indicates the UV absorbance at 280 nm measured in mAU (arbitrary units).The 
elution profile is for protein at 0.8 mg/ml injected into FPLC Hiload 16/60 Superdex 200 gel 







Figure 4.3. Dynamic Light Scattering results of purified EvpC at 6mg/ml. The 































































Figure 4.4. Mass spectrometry profile of EvpC. Native EvpC profile (top).  SeMet 





Figure 4.5. Crystal of EvpC obtained by vapor batch method with PEG3350 as precipitant.  
 
 
Figure 4.6. Asymmetric unit of EvpC (Ribbon diagram). β sheet in monomer A is shown 
in violet colour and β sheet in monomer  B is shown in yellow colour. The N and C 






4.3.2. Overall structure. 
 
 The structure of recombinant EvpC from E. tarda was solved by molecular replacement 
method using an R-axis data set and refined to 2.8Å resolution (Table 4.1). The EvpC 
model consists of residues from Ala2 to Lys163. There are two molecules in the 
asymmetric unit (Fig. 4.6.). Each monomer of EvpC mainly consists of a loosely packed 
β-barrel domain with extended loops, predominantly on one side of the β-barrel.   The β-
barrel consists of 11 anti-parallel β-strands running from one end of the molecule to the 
other.  The diameter of the inner cavity of β-barrel is approximately 12Å. An α helix 
(Ala66 - Gln76) is located on one side of the β-barrel structure. Residues from Gly35 to 
Met53 form an extended loop protruding out approximately 20Å away from the β-barrel. 
The double hexamers observed in crystal packing (symmetry related molecules) is 
facilitated by the five surface exposed loops of one monomer which are in contact with 
other monomers. Fig. 4.7 shows the ribbon diagram of an EvpC hexamer generated using 





















Table 4.1. Data collection and refinement statistics. 
Data collection High resolution 
Space group P6 
Cell dimensions   
a, b, c (Å) 85.45, 85.45, 93.07 
α, β, γ (°) 90, 90, 120 
Resolution (Å) 2.8 
Rsym or Rmerge 16.3(33.7) 
I / σI 7.5 
Completeness (%) 94.2(88.5) 
Redundancy 7.1(3.4) 
Refinement  
Resolution (Å) 29 - 2.8 
No. reflections 9074 
Rwork / Rfree 0.238/0.284 
Number of atoms  
Protein 2348 
Water 71 
 B-factors   
Protein 26.427 
 Water 26.839 
R.m.s deviations  
    Bond lengths (Å) 0.009 
    Bond angles (°) 1.25 
 
aRsym = ƩǀIi-<I>ǀ /ƩǀIiǀ where Ii is the intensity of the ith measurement, and <I> is the 
mean intensity for that reflection. 
bRwork = ƩǀFobs _ Fcalcǀ/ƩǀFobsǀ where Fcalc and Fobs are the calculated and observed 
structure factor amplitudes, respectively. 
cRfree = as for Rwork, but for 5.0% of the total reflections chosen at random and omitted 
from refinement. 





Figure 4.7. Ribbon diagram of EvpC hexamer. The diameter of the pore is about 
40Å.This figure was prepared using Pymol (http://pymol.sourceforge.net). 
 
 
Figure 4.8. Stereo view of the 2Fo-Fc electron density map.  The map is contoured at the 
level of 1.0σ. This figure was prepared using PyMol (www.pymol.org ). 
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4.3.2 Sequence and structural homology 
 
  A BLAST search (Altschul et al., 1997) with the sequence of EvpC revealed that 
it has over 100 homologs from various bacterial species or strains (~50% similarity and ~ 
35% identity). The structure based sequence alignment of EvpC with Hcp1 from P. 
aeruginosa and sequence alignment with other Hcp homologs from various 
representative pathogenic bacterial species/strains is given in Fig. 4.9. The sequence 
conservation spread through out the molecule, particularly at the N- and C-termini, and 
the MDCAS and VAVS motifs in the middle of the sequence.  The MDCAS motif is 
located in the interface between the monomers of the EvpC hexamer. The VAVS motif is 
located partly between the loop region and the β-sheet at the bottom of the hexamer. 
Sequence analysis revealed that the homologs of EvpC are well conserved among several 
pathogenic bacterial species, suggesting an evolutionary relationship and a similar 
physiological function. 
 A search for topologically similar proteins within the PDB was performed with 
the program DALI (Holm and Sander, 1996). Significant structural similarities were 
observed between the Hcp1 protein (PDB code 1y12; rmsd = 1.6Å for 158 Cα atoms; 32 
% sequence identity) from P. aeruginosa and EvpC. This is followed by the 
pyridoxamine 5’-phosphate oxidase like protein (PDB code 3ba3; rmsd=3.4Å for 101 Cα 
atoms; 11 % sequence identity). The structural and sequence homology between EvpC 
and Hcp1 strongly suggest that EvpC is a member of the Hcp1 family of proteins. Recent 
studies by Mougous et al (2006) have showed that Hcp1 is present in the lungs of patients 








Figure 4.9. Structure and sequence based alignment of EvpC. (a) Top 2 rows: Structure based 
sequence alignment of EvpC (Q6EE19), Hcp1 (PDB code 1y12, Q9I747). The amino acids are in 
one-letter codes; the conserved residues are highlighted. Strictly conserved residues are shaded 
red with semi-conserved residues lettered in red. This figure was created using the program 
ESPript (Gouet et al., 1999). Middle 3-11th rows: Sequence alignment of EvpC (top, Q6EE19) 
with the closest 10 EvpC homologs from pathogenic bacteria was carried out using ClustalW 
(Larkin et al., 2007) and ESPript (Gouet et al., 1999). Suffix: Q6EE19: EvpC, E. tarda; Q9I747: 
Hcp1, Psuedomonas aeruginosa; A1JTM5:Hypothetical protien, Yersinia enterocolitica; 
Q88IB0:Hypothetical protein, Pseudomonas putida; Q1QVA0: Hypothetical protein, 
Chromohalobacter salexigens; B1TM76:Type VI secretion system effector, Methylocella 
silvestris; Q3ZV17: Hypothetical protein, Enterobacter sakazakii; Q63IH5:Hypothetical protein, 
Burkholderia pseudomallei; Q93IS3: Putative cytoplasmic protein, Salmonella typhimurium; 





 The oligomerization state of EvpC in solution was investigated using analytical 
ultracentrifugation (AUC), dynamic light scattering (DLS) and gel filtration experiments. The 
AUC experiments on the eluted protein (~ 2mg / ml) from the Ni-NTA beads showed two 
distinct peaks. The sedimentation coefficient (S) is equal to 3.1 and 5.6 corresponding to an 
apparent molecular weight of a dimeric and hexameric EvpC, respectively. The hexameric form 
is more predominant than the dimeric form of EvpC, which is further evident from the c(M) 
values (Fig. 4.10). Also gel filtration experiment on the same eluted protein (~ 2mg /ml) showed 
a single peak corresponding to the hexameric EvpC (Fig. 4.11).  When the concentration of 
EvpC was reduced to 0.8 mg /ml, the gel filtration showed peaks corresponding to a hexameric 
and a more prominent dimeric form of EvpC (Fig. 4.2).  Further the AUC experiments on the 
dimeric fraction eluted from the gel filtration column confirmed the presence of dimeric EvpC 
(Fig.4.12). However, when the concentration of the dimeric EvpC was increased to          3 mg 
/ml, only the hexameric form of EvpC has been observed in the AUC experiments (Fig.4.13). 
Subsequently the DLS experiments on concentrated (6mg/ml) EvpC showed an apparent 
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molecular weight of 212 kDa which corresponds to two hexamers of EvpC (Fig. 4.3). The 
population of the oligomeric forms (dimer and hexamer) varies depends on the concentration of 
EvpC. However all our solution experiments suggest that hexamer is most likely the preferred 
oligomeric form of EvpC. 
 




Figure 4.10. Analytical ultra centrifugation profile of EvpC after elution from Ni-NTA beads 
(2mg/ml concentration) which shows a mixture of two oligomers a small peak with molecular 






Figure  4.11. Profile of size-exclusion chromatographic purification of EvpC which shows a single 
peak, which corresponds to an apparent molecular weight of hexamer. The X-axis indicates the 
elution volume in mL and the Y-axis indicates the UV absorbance at 280 nm measured in mAU 
(arbitrary units).The elution profile is for protein injected into FPLC Hiload 16/60 Superdex 200 gel 
filtration column (Amersham Biosciences). The molecular weight standard is shown in red colour. 
Protein concentration at 2mg/ml. 
 
 We hypothesize that the observed two different oligomeric states of EvpC may represent 
its two functional forms. The dimeric EvpC may facilitate the secretion of T6SS proteins 
including EvpP, EvpI and EvpC from inside the cell. Once it is secreted outside of the cell, EvpC 
may form a hexameric ring/tube like structure that forms a part of the translocon apparatus (Fig. 
4.14). It is worth mentioning here that a recent study on Hcp1, a close structural homolog of 
EvpC, showed that Hcp1 is capable of forming hexameric stacks which can form an extended 







Figure 4.12. Analytical ultra centrifugation profile of EvpC  from the dimer fraction of obtained 
from gel filtration which shows an apparent molecular weight of 40000 Da which is equivalent 





Figure 4.13. Analytical ultra centrifugation profile of EvpC at a higher concentration of 3 mg/ml 
which shows an apparent molecular weight of 110000 Da which is equivalent to that of hexamer. 
 
  
  Moreover, the stacked hexameric ring/tube like structure of EvpC can be observed in the 
crystal packing (Fig. 4.14). This ring/tube like structure forms a pore with a diameter of 40Å and 
this pore may be capable of transporting other T6SS proteins of appropriate diameter (less than 
2nm in radius). Electrostatic surface potential of EvpC hexamer shows that the outside of the 





Figure 4.14. Packing of the EvpC molecules in the crystal showing the tube like arrangement. 
This figure was prepared using Pymol (http://pymol.sourceforge.net).  
 
 
Figure 4.15. Electrostatic surface potential of EvpC hexamer. The outer surface is 
predominantly negative charged. Red colour represents negative charge and blue colour 
represents positive charge. The orientation is same as figure 4.7. The pore has an approximate 




4.3.5. Interaction of EvpC with other E. tarda T6SS secreted proteins  
 EvpC is crucial for the secretion of T6SS proteins in E tarda, such as EvpC, EvpP and 
EvpI (Zheng and Leung, 2007). EvpI is homologous to VgrG from V.cholerae and highly 
conserved in several bacterial species with T6SS. It has been shown that VgrG mediates the 
covalent cross-linking of actin in eukaryotic cells (Sheahan et al., 2004), and was translocated 
into macrophages in a T6SS dependent manner (Pukatzki et al., 2007).  EvpI and EvpC are 
mutually dependent for their secretion. These two proteins are also necessary for the secretion of 
EvpP. EvpP is a T6SS secreted protein present only in E.tarda, which is one of the significant 
differences in the T6SS of E. tarda compared to the T6SS in other known species (Zheng and 
Leung, 2007). We have previously showed that EvpP is present in the T6SS cluster and secreted 
out along with other proteins. Coimmunoprecipitation studies confirmed that EvpC binds with 
EvpP both intra- and extra-cellularly (Zheng and Leung, 2007). Here we report the pull down 
experiments of EvpC using GST tagged EvpP and showed that EvpP binds with EvpC (Fig. 
4.16).  Pull down assay was also performed with GST tagged EvpC1-159 (a C-terminal 4 aa 
truncated mutant). The result showed that the C-terminal deletion mutant of EvpC still interacts 
with EvpP. Furthermore, the oligomerization state of EvpP was verified using gel filtration and 
AUC experiments. The gel filtration profile shows that EvpP protein elutes as a single peak that 
corresponds to a molecular weight of 20 kDa (Fig. 4.17). In addition, analytical ultra 
centrifugation (AUC) experiments confirmed that EvpP behaves as a monomer in solution with 





Figure 4.16.  Pulldown assay studies with EvpC and EvpP. Lane1- Protein molecular weight 
marker, Lane2 - EvpC, Lane 3 - EvpP, Lane 4- Pulldown 1(EvpC bound to EvpP+GST), Lane 5 
- Molecular weight marker, Lane 6 - Pulldown 2(EvpC bound to EvpP+GST), Lane 7 - GST. 







Figure 4.17. Profile of size-exclusion chromatographic purification of  EvpP which shows a single 
peak, corresponding to monomer which corresponds to an apparent molecular weight of 20kDa. 
The X-axis indicates the elution volume in mL and the Y-axis indicates the UV absorbance at 280 
nm measured in mAU (arbitrary units).The elution profile is for protein injected into FPLC Hiload 
16/60 Superdex 200 gel filtration column (Amersham Biosciences). The molecular weight standard is 
shown in red colour. 
 
 
Figure 4.18. Analytical ultra centrifugation profile of EvpP which shows an apparent molecular 




4.3.6. Identification of key residues for the function of EvpC  
 We have carried out both sequence and structure analysis to identify the key residues of 
EvpC that are involved in the secretion of T6SS proteins as well as interaction with EvpP.  
Residues for mutation were selected based on the following criteria: (1) EvpP is highly basic 
(PI=9.47) and EvpC is acidic (PI=5.71), we speculate that the interaction between these two 
proteins is mediated by electrostatic interactions. Thus, negatively-charged residues from the 
surface exposed loop regions of EvpC were selected and targeted for site-directed mutagenesis. 
Conserved residues from both termini were also selected for the mutagenesis study. A complete 
list of all the mutants used in this study is given in the Table 4.2. Bacterial strains carrying 
single, double, triple and truncated mutants of EvpC were generated. The secretion of T6SS 
proteins in all these mutant strains listed in Table 4.3 was verified by assaying the extra-cellular 
secretion of EvpC. None of these mutant strains showed any attenuation in the secretion of 
EvpC. Subsequently, pull-down assay was carried out using the selected mutants of EvpC. The 
oligomerization states of some of these mutant proteins were also studied. It is worth mentioning 
here that mutating residue D64 into alanine has caused significant reduction in the expression of 
EvpC, but the secretion of this mutant by the bacteria was not affected. D64 is highly conserved 
among the EvpC homologs. Our result indicated that D64 is one of the key residues essential for 









Table 4.2. Strains and plasmids used in this study. 
No Strain or plasmid Description Reference or 
source 
1 pGEX4T-1 pGEX-2T derivative, Amp Pharmacia 
2 pGEXevpC pGEX4T-1 with evpC fragment This study 
3 pETMevpC6his pETM with evpC  fragment and 6His tag 
at C terminal 
This study 
4 pACYC18evpC pACYC18 with evpc  fragment   This study 
5 pETMevpP6his pETM with evpP  fragment and 6His tag 
at C terminal 
This study 
6 pGEXevpP pGEX4T-1 with evpP fragment This study 
7 pSA10 pKK177-3 derivative, lacI, Amp S. Altuvia 
8 pACYC18evpC E26A substitute residue E26 with A This study 
9 pACYC184evpCD64A substitute residue D64 with A This study 
10 pACYC184evpCE15AD18AD19A substitute residue E15,D18,D19 with  A This study 
11 pACYC184evpCE136AD141A substitute residue E136,D140 with A This study 
12 pACYC184evpC pACYC184 with evpC fragment This study 
13 pSA10evpCK161A substitute residue K161 with A This study 
14 pSA10evpCD4AD10A substitute residue D4,D10 with A This study 
15 pSA10evpC1-159 pSA10evpC with N160,K161,K162,K163 
deleted 
This study 
16 pSA10evpC11-163 pSA10evpC with N terminal 10 residues  
deleted 
This study 
17 pETMevpCE26A substitute residue E26 with A This study 
18 pETMevpCD64A substitute residue D64 with A This study 
19 pETMevpCE15AD18AD19A substitute residue E15,D18,D19 with  A This study 
20 pETMevpCE136AD141A substitute residue E136,D140 with A This study 
 
Table 4.3. EvpC mutants used for extra-cellular protein secretion assay. 
 
No Strain or plasmid Description Reference or 
source 
1 pACYC18evpC pACYC18 with evpc  fragment   This study 
2 pSA10 pKK177-3 derivative, lacI, Ampr S. Altuvia 
3 pACYC18evpC E26A substitute residue E26 with A This study 
4 pACYC184evpCD64A substitute residue D64 with A This study 
5 pACYC184evpCE15AD18AD19A substitute residue E15,D18,D19 with with 
A 
This study 
6 pACYC184evpCE136AD141A substitute residue E136,D140 with A This study 
7 pACYC184evpC pACYC184 with evpC fragment This study 
8 pSA10evpCK161A substitute residue K161 with A This study 
9 pSA10evpCD4AD10A substitute residue D4,D10 with A This study 
10 pSA10evpC1-159 pSA10evpC with N160,K161,K162,K163 
deleted 
This study 








Figure 4.19. Western blot of secretion assay profile of EvpC wild type and mutant proteins. 
Upper panel - Total cell protein, Lower panel – Secreted protein.  Lane1- Evpc wild-type, Lane 2 
- EvpC K161A, Lane 3- EvpC 1-159, Lane 4- EvpCE26A, Lane 5- EvpC D10AE26A, Lane 6- 
EvpCD4AD10AE26A, Lane 7 - EvpC D4A, Lane 8- EvpCD10A, Lane 9 - EvpCD4AD10A, 
Lane 10- EvpC 11-163 (N-terminal deletion mutant).  
 
   
 We further targeted the negatively charged residues D4, D10, D15 and E26 in the N-
terminal region of EvpC. It was observed that single mutation on these residues did not have any 
effect on the secretion of EvpC as these mutants showed a similar secretion profile as observed 
in the wild type EvpC. However, the double mutants D4AD10A and D10AE26A caused 
significant reduction in the secretion of EvpC (Fig. 4.19). Further, in order to completely abolish 
the secretion of EvpC, we have generated N-terminal triple mutants by mutating D4, D10 and 
E26 to alanine but this mutation might have caused the instability of EvpC and we could not 
detect the expression of EvpC in our experimental condition. These results suggest that the 
negatively charged residues at the N-terminal region of EvpC significantly affect the secretion of 
EvpC and thus might play an important role in the secretion function of T6SS in E. tarda. 
However mutation of more than two residues significantly affected the expression of EvpC. Thus 
a substantial reduction in the secretion of EvpC was achieved only by the mutation of two or 







 EvpC is an Hcp1 homolog which is essential for a functional T6SS in E. tarda. EvpC, 
EvpP and EvpI are the three secreted proteins in E. tarda. Our previous studies reported the 
functional importance of EvpC in T6SS and also confirmed the binding of EvpC with EvpP both 
intra and extra-cellular. The sequence alignment of EvpC and EvpI shows that the homologs of 
these proteins are present in other well known pathogenic bacterial species. Recent studies 
reported that Hcp1 from P. aeruginosa can form hexameric ring like structure (Mougous et al., 
2006). Ballister et al (2008) have showed that Hcp1 can be assembled in vitro and form nano-
tube like structures, which contain up to 25 subunits and have a length of around 100 nm. 
Further, it has been shown that the mutation of Gly90 and Arg 157 to cysteine allows the 
formation of a disulphide bridge that can stabilize the nanotube structure. In the case of EvpC, 
the gel filtration and AUC experiments confirmed the presence of two oligomeric states. Our 
experiments suggest that EvpC exists predominantly as a dimer at low concentration 
(<1.0mg/ml) and as a hexamer at high concentration. We speculate that the dimeric form of 
EvpC might be present inside the cell and the hexameric form at the outside of the cell and 
assembles a pore like structure. 
 
  Secretion of the Hcp protein (EvpC homolog) is a major criterion for a functional T6SS. 
We have carried out several mutations based on the structure of EvpC and showed that the 
negatively charged residues on the extended loop regions, particularly at the N-terminal region of 
EvpC, are involved in the secretory function. EvpC homologs are present in a number of 
pathogenic bacterial species. The results obtained from this study can be extended to other 




















 This thesis reports the structural and functional characterization of two key secretion 
system proteins – GrlR from the type III secretion system and EvpC from the type VI secretion 
system. GrlR is a major regulator protein in T3SS in E. coli, whereas, EvpC is an important 
secreted protein in T6SS from E. tarda which also facilitates the secretion of other T6SS 
proteins. We have carried out structural studies and subsequently a whole array of systematic 
functional studies such as structure based mutagenesis, pull-down studies, in-vivo secretion 
assays, isothermal titration calorimetric experiments, analytical ultra centrifugation experiments, 
and mass spectrometry studies on these proteins.  
 Attaching and effacing pathogens are a group of enteric pathogens that includes the 
closely related enterohemorrhagic E. coli (EHEC) and enteropathogenic E. coli (EPEC). EPEC 
causes severe diarrhea in young children in developing countries, while EHEC is a causative 
agent of hemorrhagic colitis. A major infection mechanism employed by EHEC and EPEC is the 
type III secretion system. T3SS is a syringe-like apparatus composed of approximately 20 
proteins that serve to transfer virulence proteins from the bacteria directly into the host 
cytoplasm. The genes encoding for the T3SS components and related proteins are organized in 
several operons that are clustered in the locus of enterocyte effacement (LEE). GrlR and GrlA 
are LEE-encoded and newly identified regulators that are common to all attaching and effacing 
pathogens. The second chapter of this thesis reports the crystal structure of GrlR and explains 
how it can bind with GrlA to influence the activity of T3SS. Furthermore, we have identified an 
EDED motif in GrlR which is crucial for the recognition of GrlA and activity. This study will 
help us understand the virulence determinants of E. coli which are important for controlling the 
diseases caused by these organisms.  
125 
 
In addition, we have demonstrated that GrlR has a lipocalin fold and performed relevant 
bioinformatic/structural analysis on the GrlR structure and proposed the binding lipid partners. 
Subsequently, the binding with the selected lipid species was verified using isothermal titration 
calorimetry experiments. This was followed by co-crystal structural studies of a GrlR-lipid 
complex. Based on these results we showed glycerophosphatidyl phosphatidic acids and 
glycerophosphatidyl ethanolamines as potential lipid ligands of GrlR. In addition, we identified 
endogenously bound lipid species of GrlR using electrospray ionization mass spectrometry. Our 
studies revealed the hitherto unknown lipid binding property of GrlR. We speculate that this 
property of GrlR may help to anchor and orient GrlR on membrane to facilitate its interaction 
with the positive regulator GrlA. 
 We have studied EvpC to understand the type VI secretion systems. EvpC belongs to the 
Hcp1 (hemolysin coregulated protein 1) family. Secretion of Hcp1 is a major criterion to identify 
a functional T6SS. EvpC is crucial for the secretion of T6SS proteins such as EvpP, EvpI and 
EvpC in E. tarda. We solved the crystal structure of EvpC and refined at 2.8 Å. Subsequently we 
have performed structure based mutational studies, in-vivo secretion assays, pull-down assays, 
isothermal titration calorimetric experiments and analytical ultra centrifugation experiments. 
Based on our studies we propose that EvpC adopts two different oligomeric states to carry out 
two distinct functions. The dimeric form of EvpC is found inside the cell required for the 
secretion of EvpC and other T6SS proteins. However, once secreted, it has the property of 
forming hexameric ring like structure with around 40Å in diameter, which can transport proteins. 
Further, our studies show that selected N terminal negatively charged residues are crucial for the 





 In GrlR we identified a key motif that is responsible for the recognition of GrlA and its 
function. It is known that GrlR binds with GrlA and this binding is crucial for its regulatory 
function. The crystal structure of GrlR-GrlA complex will clearly help us to understand the 
interactions between GrlR and GrlA.  In addition, GrlA is proposed to bind with DNA through 
its helix-turn-helix motif present in the N-terminal domain and with GrlR through its C-terminal 
domain. The proposed future work is to dissect GrlA into two domains and the function/property 
of the independent domains will be established. This is expected to be followed by the 
independent domain co-crystallization with GrlR and the respective DNA fragment. As of now, 
the DNA sequence that is recognized by GrlA is not yet established. First it needs to be identified 
and this will be followed by their co-crystal structural studies on the GrlA-DNA complex. 
Finally, a complex structure of GrlR-GrlA-DNA will give a clear picture about the regulatory 
network of these two proteins. The details of the regulatory network will help to design drugs or 
vaccines that can target the protein secretion system. Since these drugs target the secretion 
system, they have a great potential to reduce mortality associated with infection without 
generating resistant pathogenic strains. 
 EvpC is a key T6SS protein, but little is known about its function. Although the binding 
of EvpC with EvpP is known, a crystal structure of EvpC-EvpP complex is essential to get more 
insights into the binding mechanism. We generated 15 different mutants of EvpC and found that 
certain N terminal residues are responsible for the secretion function. In future we will generate 
more triple mutants of the N terminal region and perform secretion assay with the new mutants. 
We are also planning to carryout pull down assay studies on the selected mutants to verify the 
effect of mutation on the EvpC to EvpP binding. We have used EvpC as a marker protein during 
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our secretion assay experiments to verify the secretion of T6SS proteins. Secretion assay 
experiments using other secreted protein such as EvpP as a marker protein will be carried out to 
verify the effect of EvpC mutations on T6SS secretion. Along with these two proteins, EvpI is 
also secreted out in the E. tarda T6SS. Subsequent future studies will also be devoted to 
understand the role of EvpI in T6SS and its interactions with EvpC. Over all, the structural and 
functional studies on EvpP and EvpI are essential to enhance our understanding on the T6SS.  
Results from our current studies, in combination with those from the planned future 
works, are expected to provide a better understanding of the type III and type VI secretion 
systems in gram-negative bacteria. In future, these secretion systems can be targeted to design 
molecules which can block the secretion of virulence proteins. Inability to secrete the virulence 
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